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ABSTRACT 
The primary aim of this dissertation was to describe the changes in microvascular 
hematocrit, as total[hemoglobin+myoglobin] (T[Hb+Mb] measured with near-infrared 
spectroscopy (NIRS), during post-occlusive reactive hyperemia (PORH). Mechanisms of 
reactive hyperemia within skeletal muscle were also explored. The investigation detailed in 
Chapter 2 of this dissertation found that the differing time courses of the kinetic responses of  
both oxy- and deoxy[Hb+Mb], are related to changes in T[Hb+Mb]. We also determined that 
adipose tissue thickness had no effect on a purely temporal analysis of NIRS data. In Chapter 3 
we observed that brachial artery reactive hyperemia preceded changes in T[Hb+Mb] during 
reactive hyperemia. Assuming that myoglobin remained constant, we posited that changes in 
T[Hb+Mb] must reflect alterations in red blood cell concentration in the microvasculature, i.e., 
microvascular hematocrit. In Chapter 4 comparisons were made between brachial artery blood 
flow, cutaneous and skeletal muscle flux and T[Hb+Mb]. The conduit artery response was faster 
than the microvascular responses in all tissues. Within skeletal muscle, time to peak and the time 
constant for the on-kinetics were faster in T[Hb+Mb] compoared with intramuscular flux as 
measured with intramuscular laser-Doppler. We observed no differences in temporal responses 
between cutaneous and intramuscular measures and suggested that in a purely temporal analysis 
the cutaneous microvasculature could serve as an analog for the skeletal muscle 
microvasculature. Finally, in Chapter 5 we found that prostaglandin inhibition with ibuprofen 
altered the initial T[Hb+Mb] response during PORH without impacting cutaneous flux or 
brachial artery blood flow. Chapter 5 also discussed that the addition of a wrist cuff to our 
standard instrumentation prevented the accumulation of T[Hb+Mb] during the occlusion period.              
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Following a period of arterial occlusion there is a transient increase in blood flow called 
post-occlusive reactive hyperemia (PORH), or ischemia/reperfusion. During the period of 
occlusion, vasodilation of downstream arterioles occurs due to various vasodilators; when the 
occlusion is removed the decreased vascular resistance results in a temporary hyperemic state; 
eventually these vasodilators are flushed, vasodilation wanes and blood flow returns to pre-
occlusion levels. Reactive hyperemia has traditionally been assessed in the brachial artery via 
Doppler ultrasound[1, 2] and in the forearm as a whole with strain gauge plethysmography[3]. 
However, these early studies could not assess reactive hyperemia within skeletal muscle. In light 
of recent evidence suggesting that microvascular reactive hyperemia is more predictive of 
cardiovascular disease than measures derived from the conduit artery[1, 4, 5], the ability to 
assess microvascular reactive hyperemia within skeletal muscle could offer clinical utility 
beyond traditional measures.  
For over 40 years, near-infrared spectroscopy (NIRS) has been used to non-invasively 
monitor oxygen status in various tissues, including skeletal muscle [6-8]. NIRS has been used to 
assess reactive hyperemia in the lower limb in healthy subjects and in patients with peripheral 
artery disease.[9, 10] These authors suggested that the dynamic changes in 
oxyhemoglobin+myoglobin (oxy[Hb+Mb] as measured with NIRS during PORH were a better 
measure for determining microvascular dysfunction than was the amplitude of the PORH 
response. These authors were also the first to observe a transient increase in total 
hemoglobin+myoglobin (T[Hb+Mb]) during PORH. However, they provided no framework for 
the evaluation of the dynamic changes in the NIRS related signals T[Hb+Mb], oxy[Hb+Mb] and 
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deoxyhemoglobin +myoglobin (deoxy[Hb+Mb]). The investigation described in Chapter 2 
sought to rectify this issue and to provide a technique for the evaluation and quantification of 
both the dynamic changes in oxy[Hb+Mb] and deoxy[Hb+Mb] signals and their signal strength 
and to determine which had the greatest impact on T[Hb+Mb]. Briefly, this investigation showed 
that distinct sigmoidal functions are best used to describe each NIRS response (oxy[Hb+Mb] and 
deoxy[Hb+Mb]) and that the changes in T[Hb+Mb] are related to both the dynamic components 
of each response and their amplitude.  We also demonstrated that correction for adipose tissue 
thickness is not required during a purely temporal analysis of NIRS data. 
 During PORH, reactive hyperemia results in a transient increase in conduit artery blood 
flow above baseline levels; microvascular blood flow is also increased in the skin.[11, 12] 
Within the skeletal muscle microvasculature, T[Hb+Mb] also demonstrates a transient increase 
above baseline.[9, 13] A limitation of these previous studies was that no comparisons were made 
between conduit artery reactive hyperemia and reactive hyperemia within skeletal muscle itself. 
Therefore, the purpose of the investigation described in Chapter 3 was to compare the kinetic 
relationship between T[Hb+Mb] within the skeletal muscle microvasculature and the conduit 
artery macrovascular response during PORH. Recovery kinetics for both conduit artery and 
T[Hb+Mb] responses were moderately correlated and not different from one another.   Our 
results suggest that the T[Hb+Mb] response was preceded by brachial artery reactive hyperemia. 
T[Hb+Mb] reflects both skeletal muscle myoglobin and erythrocyte hemoglobin in the 
microvasculature in the area of interrogation. Assuming that myoglobin remains constant, 
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changes in T[Hb+Mb] must reflect alterations in red blood cell concentration in the 
microvasculature, i.e., microvascular hematocrit.[14, 15]   
 Comparisons between microvascular and macrovascular reactive hyperemia had 
previously demonstrated poor degrees of association,[11, 12] but our analysis demonstrated a 
moderate degree of correlation between the two and suggested causality.[16] Previous 
comparisons had only compared the cutaneous microvasculature to conduit artery during reactive 
hyperemia. The study described in Chapter 4 added cutaneous and intramuscular assessments of 
erythrocyte flux measured as with laser-Doppler flowmetry to our instrumentation. We found 
that both time to peak and the time constant of the on-kinetics during PORH were faster in the 
conduit artery compared with all microvascular measures (both cutaneous and skeletal muscle). 
Within skeletal muscle, these same parameters were faster for T[Hb+Mb] compared to 
intramuscular laser-Doppler. No differences in temporal profiles were observed between 
cutaneous and intramuscular measures, either by NIRS or IMLD, during PORH in the forearm. 
 Many vasodilators have been implicated in reactive hyperemia following arterial 
occlusion. End products of arachidonic acid metabolism, such as prostaglandins, are an often 
cited causal agent of reactive hyperemia as measured in the entire forearm with strain gauge 
plethysmography and in the conduit artery.[3, 17-19] Prostanoid production can be curtailed with 
the administration of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.[20] 
The investigation described in Chapter 5 examined the effects of prostaglandin inhibition with 
1200 mg of oral ibuprofen on the temporal parameters of the overall reactive hyperemic response 
in skeletal muscle, cutaneous tissue and the brachial artery. Our results confirm that ibuprofen 
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alters the initial T[Hb+Mb] response during PORH, resulting in a longer time to peak and a 
longer on-kinetic time constant. These results also showed that ibuprofen had no impact on the 
cutaneous or conduit artery blood flow during PORH. Chapter 5 also addresses the accumulation 
of T[Hb+Mb] during the occlusion period, a common problem in NIRS research seen in the first 
known assessment of reactive hyperemia with NIRS,[9] and in previous work in our lab[13, 16]. 
The addition of a wrist cuff, as is typically used in strain gauge plethysmography,[21] eliminated 
this problem in our study population. 
 Chapters 2 and 3 have been previously published and thus are presented in the formatting 
style of the chosen journal. Chapters 4 and 5 are currently in review. Chapter 6 provides a 
summary or the dissertation findings and offers potential future directions. References for this 
dissertation have been appended to the end of the document and are combined for simplicity.  
 
  
 6 
 
 
 
 
 
Chapter 2 - Characterizing near-infrared 
spectroscopy responses to forearm post-occlusive 
reactive hyperemia in healthy subjects 
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 ABSTRACT 
During post-occlusive reactive hyperemia (PORH) there is a temporary increase in the 
total hemoglobin + myoglobin (T[Hb+Mb]) signal as measured by near-infrared spectroscopy 
(NIRS). This transient increase predicts differences in the kinetic responses of deoxy[Hb+Mb] 
and oxy[Hb+Mb] during PORH. The purpose of this study was to determine whether sigmoidal 
(Gompertz or logistic) or exponential functions better describe these response curves during 
PORH. The fit of the three functions (exponential, Gompertz and logistic) to the NIRS 
responses, as determined from residual sum of squares, was compared using repeated measures 
ANOVA on Ranks. The Gompertz function provided a better fit to the oxy[Hb+Mb] response 
curve than did either the exponential or logistic function (χ2 = 21.7, df = 2, p<0.001). The logistic 
function provided a better fit for the deoxy[Hb+Mb] response (χ2 = 22.9, df = 2, p<0.001) than 
did either the Gompertz or exponential functions. For both NIRS signals, the better fitting 
sigmoidal functions fit the data well, with an average r value of 0.99 or greater. Adipose tissue 
thickness was correlated with parameters related to signal strength (amplitude, r = 0.86–0.89; 
baseline, r = 0.67–0.75; all p<0.001) but was not related to kinetic parameters (time constant and 
inflection point; p>0.05 for all comparisons). These results suggest that during PORH distinct 
sigmoidal mathematical functions best describe the responses of the oxy[Hb+Mb] (Gompertz) 
and deoxy[Hb+Mb] (logistic) as measured by NIRS. Further, differences in both the kinetic and 
amplitude aspects for the responses of oxy[Hb+Mb] and deoxy [Hb+Mb] predict the observed 
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transient change in T[Hb+Mb]. Our methods provide a technique to evaluate and quantify NIRS 
responses during PORH, which may have clinical utility. 
 
 INTRODUCTION 
The magnitude of the hyperemic response to brachial artery occlusion, post-occlusive 
reactive hyperemia (PORH), has been used to evaluate the relative health of the vasculature 
in both diseased and apparently healthy populations [22-24]. The limitation in these earlier 
studies is that the downstream hyperemia within skeletal muscle was not assessed; only the 
relationships between conduit artery and other easily accessible peripheral vascular beds (i.e., 
skin) were explored. An advantage of using near-infrared spectroscopy (NIRS) to assess PORH 
responses is the ability to detect changes in microvascular function within skeletal muscle itself, 
which could have significant clinical implications. For example, much of the insulin resistance 
found in obesity and type II diabetes mellitus is thought to occur in response to endothelial 
dysfunction within the capillaries of skeletal muscle[25]. The ability to compare information 
regarding microvascular function obtained from NIRS across patients or within the same patient 
over time could help inform treatment decisions. What is needed is a systematic process that 
facilitates thecomparison of these microvascular responses as measured by NIRS; this project 
seeks to lay the groundwork for such a paradigm. 
At near-infrared wavelengths the primary chromophores present in the human forearm 
are hemoglobin, myoglobin and cytochrome aa3[6]. There is an overlap in 
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the absorbance spectra of hemoglobin and myoglobin in the near-infrared spectra, rendering 
them almost indistinguishable with traditional commercial NIRS systems (but 
see [26]). Near-infrared spectroscopy (NIRS) allows for the non-invasive assessment of the 
concentration of oxygenated (oxy[Hb+Mb]) and deoxygenated hemoglobin + myoglobin 
(deoxy[Hb+Mb]) in skeletal muscle [7]. Total hemoglobin plus myoglobin (T[Hb + Mb]) is the 
sum of oxy[Hb+Mb] and deoxy[Hb+Mb]. Changes in the concentrations of these chromophores 
within skeletal muscle may provide information about microvascular function. 
During PORH if oxy[Hb+Mb] and deoxy[Hb+Mb] change with the same amplitude and 
time course, we would expect T[Hb+Mb] to remain constant. In fact, a transient increase in 
T[Hb+Mb] is observed during PORH [27]. Visual inspection of these responses following cuff 
release suggest that both have a sigmoidal shape, but that the oxy[Hb+Mb] signal changes more 
rapidly than does the deoxy[Hb+Mb] signal. This implies that oxy[Hb+Mb] and deoxy[Hb+Mb] 
change with different time courses and predicts that the oxy[Hb+Mb] and deoxy[Hb+Mb] 
response curves would be best fit by two distinct sigmoidal functions during PORH. A logistic 
function has a constant rate of change which is relatively sluggish early in the response, such as 
immediately post cuff release. This may make it a good descriptor of the changes in 
deoxy[Hb+Mb] response, but inappropriate to describe the rapid early changes observed in the 
oxy[Hb+Mb] response. On looking for an alternative function to characterize the rapid 
acceleration observed in the oxy[Hb+Mb] signal post cuff release, we chose the Gompertz 
function due to its earlier inflection point and resultant increased rate of change early in the 
response. Therefore, the purposes of this study were to: (a) Determine the best descriptor of the 
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oxy[Hb+Mb] and deoxy[Hb+Mb] responses during PORH, and (b) determine which of the 
characteristics (kinetic vs. signal strength) of the oxy[Hb+Mb] and deoxy[Hb+Mb] responses 
contributed to the transient change in T[Hb+Mb] during PORH.  Specifically, we tested these 
three hypotheses: (1) a logistic function would best describe the response of deoxy[Hb+Mb] 
during PORH, (2) a Gompertz function would best describe the response of oxy[Hb+Mb], and 
(3) the peak amplitude of change in oxy[Hb+Mb] and deoxy[Hb+Mb] would be similar, 
implying that the observed changes in T[Hb+Mb] would be related only to the distinct 
kinetics of each response. 
 METHODS 
 Subjects 
 
Twenty subjects between the ages of 18 and 26 (10 males, average age 21.6 years) were 
recruited from the general student body at Kansas State University. Informed consent was 
obtained after both written and verbal explanation about the possible risks and discomforts of  
the experi- mental protocol were given. The study was approved by the Institutional Review 
Board for Research Involving Human Subjects at Kansas State University. These subjects were 
apparently healthy and sedentary. Average adipose tissue thickness  (ATT),  measured  with  
pulsed  Doppler  ultra-sound,  under  the  NIRS  probe  was  4.62 ± 1.45 mm. Average Body 
Mass Index was 23.6 ± 3.7 kg/m2, mean resting heart rate was 66 ± 8 beats/min, mean systolic 
blood pressure was 119 ± 9 mmHg and mean diastolic blood pressure was 72 ± 7 mmHg. 
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 Protocol 
All tests were conducted between 0700 and 0830 hours, and were performed in a quiet, 
temperature-controlled room. Participants were instructed to refrain from alcohol and exercise 
for 24 h and caffeine for 12 h and were fasted. Subjects were supine and the sampled arm was 
abducted to a 45° angle. The forearm was supinated to expose the sampling site. Skeletal muscle 
oxygenation was monitored continuously using an OxiplexTS, Model 96208 (ISS, Champaign, 
IL, USA) system with the probe placed over the brachialis, flexor digitorum superficialis and 
flexor carpi radialis by a trained anatomist. This placed the distal edge of the NIRS probe 
housing approximately halfway between the wrist and the anticubital fold, with the lateral edge 
of the probe approximately along the midline of the forearm. Characterization of the OxiplexTS 
probe has been previously described in detail [28]. Briefly, the system operates at wavelengths of 
692 and 834 nm with a modulation frequency of the light-source intensity of 110 MHz. The 
probe utilized source-detector separations of 2.0, 2.5, 3.0 and 3.5 cm. The probe was fixed in 
place with an elastic strap tightened to prevent movement. The entire forearm was covered with 
an opaque cloth to prevent ambient light from influencing the NIRS results. For each trial, NIRS 
measurements were collected continuously during 1 min of rest, 5 min of brachial artery 
occlusion and 150 s of reactive hyperemia. Total collection time per trial was 8.5 min. The 
protocol was repeated a total of three times with a 10 min rest period between trials. Occlusion of 
the brachial artery was accomplished by rapid (within 2 s) inflation, by hand, of a blood pressure 
cuff to [250 mmHg. The cuff was placed just proximal to the elbow.  Complete occlusion of the  
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brachial  artery  was assumed if the T[Hb+Mb] signal did not increase following cuff inflation. 
All NIRS data were time aligned to cuff release (t = 0) and averaged across trials. 
 Statistical analysis 
All data were imported into SigmaPlot 10 with SigmaStat 3.5 (Systat Software, Inc., SanJose, 
CA, USA). Logistic (Eq. 1), Gompertz (Eq. 2) and exponential (eq. 3) functions were fit to both 
the oxy[Hb+Mb] and deoxy[Hb+Mb] responses producing six response curves per subject. 
Y = Y0+a/(1+e
-(X-X0)/b)  (1) 
Y = Y0+ae
-e-(X-X0)/b
   (2) 
Y = Y0 + a(1-e
-(X-X0)/b)  (3)   
For each equation, ‘‘Y0’’ represents the baseline (end-cuff occlusion) value, ‘‘a’’ represents the 
signal amplitude, ‘‘X’’ is time, ‘‘b’’ represents a time constant, and ‘‘X0’’ represents the time at 
the inflection point of each curve (Eqs. 1, 2) or time delay (Eq. 3) (Fig. 1). Y0 was determined 
from the last 20 s of the 5-minute cuff occlusion. Goodness of fit for each function was 
determined by examining residual sum of square (RSS) values. We had originally planned to use 
the ΔAkaike method to compare our response curves (since the three functions are not nested 
models), but since all three models had the same number (four) of parameters, the equation 
reduced to RSS times a similar constant across models and subjects. Repeated measures 
ANOVA on ranks was thus used to compare the RSS values from each function within each 
response.  
Parameter estimates from the best fitting function for each response were plotted against 
ATT for each subject. Pearson product moment correlation was then performed between ATT 
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and the uncorrected parameter estimates. The slope of this line was used to correct each 
parameter estimate affected by ATT (amplitude a, and baseline Y0). Due to unequal variance, for 
corrected and uncorrected amplitude (a) values a Kruskal–Wallis One Way Analysis of Variance 
on Ranks analysis was performed. One way ANOVA was performed on the corrected and 
uncorrected baseline (Y0) values. Tukey’s post-hoc analysis was used to determine group 
differences for both variables. Kinetic parameters (time constant b and inflection point X0) were 
not influenced by ATT and, therefore, correction for ATT was not necessary. These parameters 
were compared with paired t tests. 
 RESULTS 
Figure 2 shows the T[Hb+Mb], oxy[Hb+Mb] and deoxy[Hb+Mb] responses across the 
entire experiment for one representative subject through baseline data collection, cuff occlusion 
and PORH following cuff release. Upon cuff release, while the time course of changes in 
oxy[Hb+Mb] and deoxy[Hb+Mb] appeared  similar, they were not identical as demonstrated in    
Fig. 3. Oxy[Hb+Mb]increased as soon as the cuff was released. However, the deoxy[Hb+Mb] 
response had a slower rate of change for approximately the first 20 s before the dynamic 
hyperemic response occurred. The result of these disparate kinetics was that T[Hb+Mb] shows a 
transient increase following cuff release (Fig. 1). 
Figure 4shows combined deoxy[Hb+Mb] and oxy[Hb+Mb] response curves and residuals 
for the same subject as in Figs. 2 and 3 fit with Gompertz, logistic and exponential functions. 
Tables 1 and 2 show the RSS data for all subjects for the three functions fit to the 
deoxy[Hb+Mb] and oxy[Hb+Mb] responses, respectively. For both responses a sigmoidal curve 
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provided the better fit on average compared to the exponential function (deoxy[Hb+Mb]: χ2 = 
22.9, df = 2, p < 0.001; oxy[Hb+Mb];χ2 = 21.7, df = 2, p< 0.001). Post-hoc analysis revealed 
that the logistic function provided the best fit of the three functions tested for the deoxy[Hb+Mb] 
response; there was no significant difference between the fit of the exponential and the Gompertz 
functions. Conversely, the Gompertz function provided the best fit for the oxy[Hb+Mb] response 
when  compared  with  both  the  exponential  and  logistic functions; there was no significant 
difference between the RSS values for the logistic and exponential functions. Since the 
exponential function was not the best fit on average for either response, it was excluded from 
further analyses. 
Amplitude (a) and baseline (Y0), but not time constant (b) and time of inflection point 
(X0) (data not shown) were significantly correlated with ATT for all response curves(Fig. 5). 
Table 3 gives the average parameter estimates, uncorrected- and corrected-for-ATT where 
appropriate, for the best fit model (logistic for the deoxy[Hb+Mb] response and Gompertz for the 
oxy[Hb+Mb] response) across all subjects.  Correcting for ATT resulted in a significant increase 
in the baseline (Y0) and amplitude (a) values for both the oxy[Hb+Mb] and deoxy[Hb+Mb]  
responses (F = 367.82, df = 3, p < 0.001). For the Gompertz function fit to the oxy[Hb+Mb] 
response, the time constant (b) was significantly greater, and the inflection point (X0) was 
significantly smaller (both  p< 0.001) compared to the corresponding value for the logistic 
function fit to the deoxy[Hb+Mb] (Table 3). 
The relationship between the amplitude for deoxy[Hb+Mb] and oxy[Hb+Mb], both for 
the uncorrected and corrected-for-ATT values, for all subjects is further illustrated in Fig. 6. 
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Note that while there was a strong relationship between the amplitudes of the two responses 
across subjects, most of the amplitudes for oxy[Hb+Mb] fell below amplitude of 
deoxy[Hb+Mb]),  for  both  uncorrected  and corrected data. Figure 7 shows the relationships for 
the best fit model (oxy[Hb+Mb] fit with the Gompertz function and deoxy[Hb+Mb] fit with the 
logistic function) for both kinetic parameters (b and X0) across all subjects. While both b and X0  
were consistently above the line of identity (i.e., deoxy[Hb+Mb]  values  smaller  than  the  
corresponding oxy[Hb+Mb] for b, but greater for X0), nonetheless there were strong correlations 
across the range of values (i.e., subjects with faster responses (smaller b and X0) in one response 
also showed faster responses in the other). 
 DISCUSSION 
The main findings of this investigation are that, consistent with hypotheses 1 and 2, a 
Gompertz function provided a better fit, on average, for the oxy[Hb+Mb], while a logistic 
function fit the deoxy[Hb+Mb] responses best, during PORH. Further, in contrast to hypothesis 
3, while the amplitudes of change during PORH for both oxy- and deoxy[Hb+Mb] were similar, 
they were not identical. This difference in amplitudes, combined with the difference in kinetics 
of adjustment between the Gompertz and logistic functions, would predictably lead to a transient 
change in the T[Hb+Mb] signal, as was seen in the present study. 
Exponential functions have typically been used to describe NIRS responses during 
dynamic exercise[29-31], following maximal 3 s contractions in the human forearm and during 
120 s of 1 Hz twitch contractions at various intensities in the rat hindlimb preparation[32-34]. In 
contrast, we found that the sigmoidal functions provided a better fit to NIRS data during PORH 
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than the exponential function in 85% (34 of 40) of the responses modeled here (17 of 20 
responses  each  for  oxy[Hb+Mb]  and  deoxy[Hb+Mb]). Interestingly, two of the three 
exceptions occurred in the same subjects (subjects 5 and 13 in Tables 1, 2) (i.e., both 
oxy[Hb+Mb] and deoxy[Hb+Mb] responses were initially best described as exponential in these 
two subjects). However, when these exponential fits were examined more closely, it was noted 
that the amplitudes of the best fit function greatly exceeded the actual amplitude of the response 
(e.g., see Fig. 1). When the amplitude of the exponential function was constrained to the real 
amplitude of the responses, the resulting RSS was greater than that of the corresponding best fit 
sigmoidal function. We, thus, conclude that our overall observations that the logistic function 
best fit the deoxy[Hb+Mb] data, while the oxy[Hb+Mb] data were best described by the 
Gompertz function, was also true for these subjects (#5, 13, 14 and 16). These results 
demonstrate that modeling techniques that are appropriate for data obtained during or in recovery 
from exercise may not provide an appropriate description of the NIRS data obtained following 5 
min of ischemia during PORH. Taken together, these findings suggest that care must be taken 
when selecting a function for mathematical modeling of NIRS response data. 
To our knowledge, only Kragelj et al.[27] have previously examined tissue oxygenation 
during PORH using NIRS. Their model was tissue oxygenation of the foot during and after cuff 
occlusion of the popliteal artery. While their data analysis was model-independent, their overall 
observations were similar to those of the present study, i.e., that the kinetics of the oxy[Hb+Mb] 
response were faster than those of deoxy[Hb+Mb] during PORH. 
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Amplitude and baseline values which are related to signal strength, were significantly 
correlated with ATT, while the kinetic parameters, slope and inflection point, were not. These 
results suggest that ATT does not affect the kinetic characteristics of the response, only the 
signal strength, and that correction for ATT is not required when performing a purely temporal 
analysis. 
The NIRS signal primarily emanates from skeletal muscle [Mb] and the microvasculature 
[Hb] (Liu et al. 1995)[35]. Assuming all of the transient increase in T[Hb+Mb] is due to 
increased [Hb] (with skeletal muscle [Mb] remaining constant) the increased T[Hb+Mb] signal 
likely represents increased microvascular  hematocrit[36-38]. However, the underlying reasons 
for the temporal differences observed in the oxy- and deoxy[Hb+Mb] responses during PORH 
are not known. One potential mechanism for the delayed response of deoxy[Hb+Mb]  compared  
to oxy[Hb+Mb] during PORH may involve additional unloading of oxygen during the early 
recovery phase of PORH to refill tissue Mb stores utilized during the ischemic period. Tran et 
al.[39] demonstrated that during cuff ischemia  of  the  lower  leg,  Mb  desaturation  by  NMR 
reached a maximum value by *4.5 min. Given that Mb content of human skeletal muscle is 
greater than previously thought[26, 40], the dynamics of Mb de/resaturation may contribute 
significantly to the overall kinetics of the NIRS responses during PORH. Consistent with this, 
the observed time to the inflection point (X0) for deoxy[Hb+Mb] in the present study (16.9 s) 
is similar to the time constants for Mb resaturation reported by Duteil et al.[41]. 
It should be noted that one limitation of the present analysis is that only 3 models 
(exponential, logistic and Gompertz) were compared. There could be another, unidentified model 
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which may provide an even better fit to the response curve data. In addition, our subjects were a 
relatively young, healthy cohort. It is currently unclear to what extent our findings and approach 
to data analysis may be  applicable  to  clinical  populations.  We expect any pathological 
condition affecting vascular function, such as diabetes, heart failure and peripheral vascular 
disease, would  alter  the  kinetics  and  possibly  amplitude  of  the observed   deoxy[Hb+Mb]   
and   oxy[Hb+Mb]   responses,which in turn might alter the T[Hb+Mb] response. In fact, Kragelj 
et al.[27] observed slowing of the NIRS responses in patients with peripheral vascular disease. 
Many of the signs of microvascular dysfunction predate a clinical diagnosis and may, therefore, 
be useful as novel markers of disease risk, disease progression and treatment efficacy[25]. 
Evaluation of the impact of diseases which affect microvascular circulation must await future 
studies. 
 CONCLUSION 
Our findings support our initial hypotheses that during PORH, sigmoidal functions do fit 
the NIRS data better than an exponential  function and  specifically that the oxy[Hb+Mb] 
response is best described by a Gompertz function, while the logistic function provides a better 
fit for the deoxy[Hb+Mb] response. The distinct time courses of these responses in combination 
with their different response amplitudes, leads to a transient increase in T[Hb+Mb]. While the 
exact mechanism for the delayed response of deoxy[Hb+Mb] relative to that of oxy[Hb+Mb] is 
currently unknown, we speculate that it likely relates to sustained unloading of O2 from Hb 
during the early phase of PORH to restore tissue MbO2  stores. 
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Table 2-1: RSS values for all functions fir to the deoxy[Hb+Mb] response 
 
 
 
 
 
 
 
 
 
 
 
 
 
N is the number of data points in regression, equal to 20s baseline data plus time from cuff 
release until peak response. RSS is residual sum of squared errors for Gompertz (RSSG), logistic 
(RSSL) and exponential (RSSE) functions 
*Significantly different from both RSSG and RSSE 
 
 
 
Subject RSSG RSSL RSSE N 
1 11.1 3.3 10.2 64 
2 34.7 16.2 77.9 70 
3 402 294 310 60 
4 1335 1189 1267 63 
5 194 94.8 59.8 124 
6 339 224 240 77 
7 11.5 6.3 19.3 67 
8 6.9 2.5 13.6 69 
9 304 261 453 68 
10 237 127 132 63 
11 329 255 328 93 
12 4.8 1.9 16.5 83 
13 14.6 7.2 2.3 101 
14 5.8 2.2 20.6 87 
15 226 121 124 115 
16 325 196 175 97 
17 35.3 13.4 27.6 88 
18 63.9 23.0 75.7 123 
19 211 153 202 63 
20 48.7 21.5 67.8 59 
     
Ave 207 150 * 181 82 
SD 300 265 285 21 
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Table 2-2: RSS values for all functions fit to the oxy[Hb+Mb] response 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N is the number of data points in regression, equal to 20s baseline data plus time from cuff 
release until peak response. RSS is residual sum of squared errors for Gompertz (RSSG), logistic 
(RSSL) and exponential (RSSE) functions*Significantly different from both RSSL and RSSE 
Subject RSSG RSSL RSSE N 
1 17.0 22.3 23.5 51 
2 83.2 99.9 102 57 
3 668 678 841 55 
4 1424 1611 1594 61 
5 247 315 226 109 
6 339 347 368 47 
7 32.6 38.1 32.9 52 
8 10.9 17.0 12.8 60 
9 844 854 958 56 
10 383 383 556 63 
11 587 666 806 46 
12 14.8 16.8 17.6 58 
13 13.8 18.2 11.2 95 
14 29.9 45.6 19.4 78 
15 144 164 233 72 
16 440 455 489 62 
17 27.0 37.6 34.3 74 
18 95.0 97.2 159 74 
19 273 285 559 55 
20 89.4 131 95.3 52 
Ave 288* 314 357 64 
SD 363 396 424 16 
 22 
 
 
 
 
 
Table 2-3: Parameter estimates for the best fit model for deoxy[Hb+Mb] and oxy[Hb+Mb], 
uncorrected- and corrected-for-ATT 
  Y0 (µM)  a (µM) b (s) X0 (s) 
Deoxy[Hb+Mb] (Logistic)     
 Uncorrected 12.7±4.5 30.2±15.7 -5.3±2.0  16.9±6.8 
 Corrected 21.5±3.3 
c
 71.8±7.2
 c
   
Oxy[Hb+Mb] (Gompertz)     
 Uncorrected 37.5±7.2 
b
 33.8±17.3 
a
 7.4±2.4 
b
 9.4±4.0 
b
 
 Corrected 53.8±4.7
 bc
 75.1±8.9
 ac
   
 
Values are mean± standard deviation. See eqs. 1 and 2 for meaning of symbols 
Significant difference between Oxy[Hb+Mb] and Deoxy[Hb+Mb] vales:
a
 p<0.02 and 
b
 p<0.001. 
c
Significantly different from uncorrected-for-ATT values (p<0.001). 
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Figure 2-1: Schematic showing Gompertz (A) and exponential (B) functions fit to the 
oxy[Hb+Mb] data in Fig. 2. Y0 denotes baseline, a is the amplitude of the response, b is the 
time constant, and X0 is the time of the inflection point (A) or the time delay (B). 
Parameters have same meaning for logistic function as for Gompertz. See text and Eqs. 1-3 
for more information. 
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Figure 2-2: Complete experiment for one subject. Cuff inflation occurred after 60s of 
baseline data collection, and was maintained for 5 min. Post-occlusive reactive hyperemia 
(PORH) was monitored for 120s in this example.   
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Figure 2-3: : Oxy[Hb+Mb] and deoxy[Hb+Mb] response curves during PORH from the 
same subject as Fig. 1. Deoxy[Hb+Mb] response has been inverted for comparison. Time 
point 0 indicates cuff release. 
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Figure 2-4: Example of Gompertz, logistic and exponential fits to data. Note especially the 
poor fit of the exponential function to the deoxy[Hb+Mb] signal, and the projection of 
exponential fit past plateau of both responses (shown by arrows) 
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Figure 2-5 Original (circles) and corrected (triangles) baseline (Y0), amplitude (a) and time 
constant (b) values plotted against ATT:  
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Figure 2-6: Amplitudes (a) for deoxy[Hb+Mb]compared to oxy[Hb+Mb] for uncorrected- 
(top panel) and corrected-for-ATT (bottom panel). Dotted line represents line of identity 
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Figure 2-7: Time constant (b) and time inflection point (X0) during PORH for 
deoxy[Hb+Mb] compared to oxy[Hb+Mb]. Dotted line represents line of identity. 
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Chapter 3 - Relationship between brachial 
artery blood flow and total 
[hemoglobin+myoglobin] during post-
occlusive reactive hyperemia 
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 ABSTRACT 
The associations between macrovascular and microvascular responses reported 
previously during post-occlusive reactive hyperemia have been inconsistent. The purpose of this 
study was therefore to determine the temporal relationship between the reactive hyperemic 
responses within a conduit artery and the downstream microvessels. Conduit artery blood ﬂow 
was measured in the brachial artery with pulsed Doppler ultrasound. A potential analog of 
microvascular ﬂow, changes in skeletal muscle total[hemoglobin + myoglobin] (T[Hb + Mb]), 
was assessed with near-infrared spectroscopy (NIRS). We found a high degree of correlation 
between these two measures (r = 0.91). Cross-correlation analysis revealed two distinct response 
patterns. In 10 of our 15 subjects there was time displacement between peak brachial artery 
blood ﬂow (BABF) and T[Hb + Mb] responses; in the remaining 5 the peaks were coincident. 
Granger causality testing suggested that reactive hyperemia in the macrovessel determined 
hyperemia in the downstream microvessels in all 15 study subjects. Time constants for the on 
(τ1) and off (τ2) kinetics of each response were calculated; our initial hypothesis was that τ1 and 
τ2 for T[Hb + Mb] would correlate with τ1 and τ2 for BABF, respectively. However, only for τ2 
was this observed (r = 0.52; p < 0.05). No similar relationship was observed for τ1. Adipose 
tissue thickness did not inﬂuence either time constant for T[Hb + Mb]. Taken together, our 
results show that the temporal characteristics of the hyperemic response in the conduit artery are 
qualitatively reﬂected in the downstream microvasculature, but mechanisms for quantitative 
differences remain to be identiﬁed. 
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 INTRODUCTION 
Post-occlusive reactive hyperemia (PORH) has been used to assess both microvascular 
and conduit artery vascular reactivity[2, 42]. Reactive hyperemia and ﬂow- mediated dilation 
(FMD) are related phenomena. During occlusion of a conduit artery there is dilation of 
downstream arterioles, caused by metabolic and prostaglandin dilators[17, 43] which decreases 
vascular resistance. Upon cuff release, the decreased resistance to ﬂow results in hyperemia 
which, in turn, increases shear rate in the conduit artery, resulting in FMD[44]. Abnormal FMD 
has been linked to increased cardiovascular disease risk in apparently healthy individuals[24] and 
in clinical populations including post-menopausal women[22], cardiac patients[45-47] and those 
with metabolic syndrome[23]. In addition, type II diabetes results in slowed time to peak 
response for cutaneous blood ﬂow as measured with laser Doppler ﬂowmetry[48], suggesting 
abnormal microvascular reactive hyperemia. 
Although a transient increase in both conduit artery and microvascular blood ﬂow occurs 
during PORH, the relationship between the two remains unclear. Previous comparisons between 
the reactive hyperemic responses in the microvasculature and the macrovasculature have shown 
little association[12, 49]. Dhindsa and colleagues compared 7 different measures of 
microvascular and macrovascular reactivity[11]. For microvascular measures, the response was 
characterized either by a steady-state change or by the peak response observed during the 
reactive hyperemia. While the majority of their comparisons were not signiﬁcant, both FMD and 
macrovascular reactive hyperemia were signiﬁcantly correlated with measures of cutaneous 
microvascular reactive hyperemia, as measured at the ﬁngertip. Yet, no technique was employed 
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that was capable of measuring reactive hyperemia within the skeletal muscle microvasculature. 
This is an important distinction as it has been speculated that cutaneous vascular reactivity may 
not be a good surrogate for skeletal muscle microvascular reactivity[50]. Since endothelial 
dysfunction in the microvasculature of skeletal muscle is thought to be a major contributor to 
much of the elevated plasma glucose and insulin resistance seen in type II diabetes and 
obesity[25], a signiﬁcant advance would be a non-invasive technique that would allow for the 
assessment of microvascular reactivity in skeletal muscle. 
Near-infrared spectroscopy (NIRS) is an emerging clinical tool that is capable of non-
invasive determination of the oxygenation of skeletal muscle. One advantage of  NIRS is the 
ability to measure the oxygenation changes of hemoglobin + myoglobin ([Hb + Mb]) within 
skeletal muscle microvasculature. During PORH there is a transient increase in both brachial 
artery blood ﬂow and T[Hb + Mb] as determined by NIRS[27]. Currently, NIRS has found 
clinical utility in the qualitative assessment of oxygenation at the thenar eminence during 
PORH[51]. This application has shown utility in distinguishing severely ill patients, but is not 
without its limitations. While the thenar eminence is readily accessible, some authors suggest 
that the forearm measurement sites are more sensitive than the thenar site to alterations in blood 
ﬂow[52]. 
The inconsistent correlations between microvascular and macrovascular responses during 
PORH suggest that comparing peak responses among disparate variables may not be the most 
sensitive analytical approach. We propose that analyzing the time course of changes in 
microvascular T[Hb + Mb] as a potential surrogate for microvascular ﬂow and conduit artery 
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blood ﬂow may provide a better technique for investigating these relationships between micro- 
and macrovascular reactivity. To our knowledge, the kinetic relationship between the skeletal 
muscle microvascular and limb macrovascular reactive hyperemia during PORH has not been 
assessed. Therefore the purpose of this study was to determine the temporal relationship between 
forearm skeletal muscle T[Hb + Mb] and brachial artery blood ﬂow (BABF) during PORH. 
Speciﬁcally, we hypothesized that the time constants for both the on and off kinetics for T[Hb + 
Mb] would correlate with the respective on and off kinetics for BABF. 
 METHODS 
 Subjects 
Fifteen subjects (8 males) between the ages of 18 and 26 (average 21.4 years) were 
recruited from the general student body at Kansas State University. Table 1 shows subject 
characteristics. These subjects were sedentary and apparently healthy. The study was approved 
by the Institutional Review Board for Research Involving Human Subjects at Kansas State 
University. No significant differences were observed between males and females in terms of 
reactive hyperemic responses, so all data were pooled. 
 Protocol 
All tests were conducted between 7:00 and 8:30 am, and were performed in a quiet, 
temperature-controlled room. Participants were fasted overnight, had abstained from alcohol and 
exercise for 24 h and from caffeine for 12 h. 
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 Microvascular reactive hyperemia 
Skeletal muscle oxygenation was monitored continuously using an OxiplexTS, model 
96208 (ISS, Inc., Champaign, IL, USA) system with the probe placed over the brachioradialis, 
ﬂexor carpi radialis, ﬂexor digitorum superﬁcialis and pronator teres muscles. The OptiplexTS 
system has been previously described[28]. NIRS measurements were collected continuously 
during a 1 min baseline period, 5 min of brachial artery occlusion and 150 s of reactive 
hyperemia. The protocol was repeated a total of three times with a 10 min rest period between 
trials. Occlusion of the brachial artery was accomplished by rapid inﬂation by hand pump and 
within 1–2 s of a blood pressure cuff to N 250 mm Hg. Complete occlusion of the brachial artery 
was assumed if the T[Hb + Mb] signal did not increase more than 10% following cuff inﬂation. 
All NIRS data were time aligned to cuff release (t = 0) and averaged across the three trials within 
each subject. 
 Macrovascular reactive hyperemia 
Brachial artery blood velocity was measured with pulsed Doppler ultrasound (GE 
VIVID3, GE Medical Systems). Discontinuous longitudinal BA images and beat-by-beat 
velocity tracings (three at rest, one during the last minute of occlusion, one every 5 s for the ﬁrst 
30 s of post- occlusion, and then every 10 s for the remainder of post-occlusion) were obtained, 
coded, and stored on the ultrasound hard drive. BA diameter was measured with electronic 
calipers as the anterior to posterior endothelial–lumen interface and determined from an average 
of 3 successive cardiac cycles, 3 measurements / cardiac cycle, both for the widest diameter and 
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narrowest diameter. BABF for each time point was calculated as average velocity × π(average 
diameter/2)
2
. 
 Data analysis 
All data were transferred to SigmaPlot 10 (Systat Software, Inc., San Jose, CA, USA) and 
response curves were plotted for both BABF and T[Hb + Mb]. A double exponential function 
(Eq. (1)) with no time delay was ﬁt to each response curve and time constants (τ) for BABF and 
T[Hb + Mb] were recorded for both the rise from baseline to peak value (τ1) and for the return 
from peak to baseline values (τ2). Also recorded were baseline values (Y0) and two amplitude 
values (A1 and A2) corresponding to the amplitude of the rise to peak and the subsequent return 
towards baseline from peak, respectively (see Fig. 1). 
Y= Y0 +A1*(1-e
(-t/tau1)-A2*(1-exp
(-t/tau2))    (1) 
We have previously found that correction for adipose tissue thick- ness (ATT) is not required 
when performing a temporal analysis of the parameters (i.e., time constants) on oxy- and 
deoxy[Hb + Mb] response curves during PORH[13]. However, parameters (τ1, τ2, A1, A2, and 
Y0) from the T[Hb + Mb] response were plotted against ATT to determine if ATT inﬂuenced the 
results and if correction for adipose tissue thickness was required for these parameters. 
 Statistical analysis 
Both τ1 and τ2 were compared between BABF and T[Hb + Mb] using a 2-tailed, paired t-
test. Ratios of τ2/τ1for both response curves were calculated. Correlation among time constants 
was assessed with Pearson product moment correlation; these relationships were demonstrated 
with scatter plots. Signiﬁcance was declared for p < 0.05. Data were also imported into SPSS 
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version 18 (SPSS, Chicago, IL, USA) for cross-correlation analysis to determine the lead or lag 
time between T[Hb + Mb] and BABF. In this analysis the BABF data was anchored and the 
NIRS data was displaced. Cross-correlation analysis requires an equal time interval between data 
points. While NIRS data was captured continuously, BABF data was not; therefore the BABF 
data was interpolated to generate second by second data. Cross-correlation analysis to ± 15 lags 
was then performed to determine the degree of association between BABF and T[Hb + Mb] and 
the time displacement between the peak values of BABF and T[Hb + Mb]. Finally, data was 
imported into Stata 12 (College Station, Texas, USA) and Granger causality testing was 
performed to determine if past events in one response variable predicted future events in the 
other response variable. 
 RESULTS 
Two distinct response proﬁles were seen in our subjects. Fig. 1 shows a temporal 
displacement between brachial artery blood ﬂow and T[Hb + Mb] responses in one subject; this 
proﬁle was seen in 10 of 15 subjects. The average time displacement between peak values for 
these 10 subjects was 3.7 s (range 1–7 s). Fig. 2 shows no temporal displacement between the 
responses in another subject (true for 5 sub- jects). Table 2 shows the correlation and cross-
correlation coefﬁcients and time displacement data for all subjects. The correlation between 
brachial artery blood ﬂow and T[Hb + Mb] responses for individual subjects ranged between 
0.79 and 0.98 (for all, p < 0.0001), while the average correlation for pooled data was 0.91 (p < 
0.0001). In no subject did T[Hb + Mb] peak before BABF. 
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Relationships among the temporal parameters are illustrated in Fig. 3. There was no 
relationship between the rate of rise in T[Hb + Mb] following cuff release (τ1 T[Hb + Mb]) and 
that of BABF (τ1 BABF) (Fig. 3A). In contrast, the subsequent recoveries of both variables 
towards resting baseline (τ2 for both, Fig 3B) were signiﬁcantly related (r = 0.52, p< 0.05). τ1and 
τ2 for BABF showed a moderate inverse association (r = −0.63, p = 0.01) (Fig. 3, panel C); while 
τ1and τ2 for T[Hb + Mb] did not (r = 0.4) (Fig. 3, panel D). Table 3 shows the  
individual time constants (τ1 and τ2) for both response curves. τ1 was significantly faster than τ2 
for both BABF and T[Hb + Mb] (p ≤ 0.001, for both). τ1 for BABF was faster than τ1 for T[Hb + 
Mb] (p ≤ 0.001). However, there was no signiﬁcant difference between the recovery kinetics (τ2). 
Lag time in seconds was positively correlated with τ1T[Hb+Mb] (r = 0.55, p = 0.03). Finally, the 
ratios of τ2 BABF/τ1 and τ2 T[Hb + Mb]/τ1 showed large intersubject variability and were not 
signiﬁcantly different from each other; they were signiﬁcantly correlated (r = 0.52, p = 0.049). 
ATT did not inﬂuence either time constant for T[Hb + Mb] as demonstrated by the poor degree 
of association between ATT and both τ1 (r = 0.30) and τ2 (r = 0.43). 
Table 4 lists non-temporal model parameters. A1 was highly correlated with A2 for BABF 
and for T[Hb + Mb] (for both r = 0.99, p < 0.0001). However, unlike the time constants, there 
were no signiﬁcant correlations for the corresponding amplitude values between BABF and 
T[Hb + Mb]. As expected, baseline T[Hb + Mb] (Y0) was inﬂuenced by ATT (r = − 0.91, p < 
0.0001) as was both A1 (r = 0.58, p = 0.024) and A2 (r = 0.58, p = 0.03). Fig. 4 shows the 
uncorrected- and corrected-for-ATT baseline (Y0), and A1 and A2 values for T[Hb + Mb] plotted 
against ATT. 
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 DISCUSSION 
This is the ﬁrst investigation that we are aware of to compare BABF and T[Hb + Mb] 
during reactive hyperemia. As predicted, these two response variables were highly correlated (r = 
0.91, p < 0.0001). Although no correlation was noted between the time constants for the on 
kinetics, the main ﬁnding of this investigation was the correlation between the time constants for 
the off kinetics. In addition, we found a spectrum of relationships between the peaks of BABF 
and T[Hb + Mb] ranging from temporal coincidence (lag = 0 s)  to  a  lag  in  T [Hb + Mb] of 7 s. 
Our investigation also conﬁrmed that temporal parameters of the NIRS signal were not 
inﬂuenced by ATT. 
Previous investigators have reported little association between measures of microvascular 
and macrovascular reactivity[11, 53]. However, microvascular reactivity in these studies was 
determined in primarily cutaneous vascular beds, which may have different mechanisms of 
control and sensitivity to stimuli (e.g., ischemia) than the microvasculature of skeletal 
muscle[50]. If a lack of association between measures of vascular reactivity in these previous 
investigations indicates that each technique is providing information on distinct physiological 
mechanisms, the high level of association between the BABF and T[Hb + Mb] responses in the 
present investigation leads us to conclude that similar mechanisms are responsible for both the 
BABF and T[Hb + Mb] responses during PORH. Further, our results suggested that the brachial 
artery reactive hyperemia preceded the reactive hyperemic response in the downstream skeletal 
muscle. Nakamura et al. reported that blood ﬂow is coordinated between upstream conduit 
vessels and downstream peripheral tissue in the lower limb [54]. We utilized Granger causality 
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testing to determine if this relationship existed in the forearm, and found that for all 15 of our 
subjects the conduit artery response predicted the microvascular response (p < 0.001). However, 
in 3 of our sub- jects, the reverse was also true, i.e., the microvascular response also predicted the 
conduit artery response. All 3 of these subjects were among the group where there was no lag 
between peak responses. Therefore, based upon Granger criteria, the conduit artery reactive 
hyperemia caused the microvascular hyperemia in 80% of our sample. Granger causality testing 
is used to evaluate if past events in one data set predict future events in another set of data. It is 
possible that this technique failed in these 3 subjects because the peak response in both vascular 
compartments was achieved at the same time [55]. 
We hypothesized that the time constants for the on and off kinetics for T[Hb + Mb] 
would correlate with the on and off kinetics for BABF. While comparisons between 
microvascular and macrovascular blood ﬂow in the human forearm have been made previously, 
we believe that this investigation is the ﬁrst to compare the temporal parameters of T[Hb + Mb] 
during reactive hyperemia, as measured via near- infrared spectroscopy, and brachial artery 
blood ﬂow. We found no correlation between the on kinetics of the two responses, possibly 
because the time to attain peak values was quite short and contained a limited number of data 
points; we therefore had poor conﬁdence in τ1 estimates. However, the off kinetics (as τ2) for our 
two measures were not signiﬁcantly different from each other and were moderately, posi- tively 
correlated (see Fig. 3), i.e., individuals with longer conduit artery recovery times also had longer 
recovery times for T[Hb + Mb]. We believe that this association is related to vascular 
compliance in the forearm. 
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While conduit artery and microvascular reactive hyperemic responses were highly 
correlated; correlation coefﬁcients between these two responses did vary among subjects (range 
= 0.79–0.98). The lowest correlation coefﬁcients were seen in those subjects with the largest 
time displacement between the attainment of peak responses. In only 5 of our 15 subjects was the 
peak response in these measures achieved at the same time (3 if we used the Granger causality 
results). In the remaining 10 subjects there was displacement between peak BABF and peak 
T[Hb + Mb] responses. We believe that this reﬂects differences in compliance somewhere in the 
arterial tree between the brachial artery and the forearm microvasculature. In support of this, 
there was a positive correlation (r = 0.553, p = 0.03) between lag duration and τ1T[Hb + Mb], 
e.g., the longer lag was associated with a longer time to peak response. Those subjects who 
demonstrated no lag between peak responses could have reduced compliance in the forearm 
arterial tree. None of the subjects reported any symptoms nor displayed signs of metabolic or 
cardiovascular disease during the screening process which could have affected arterial 
compliance, but we cannot rule out that subclinical disease was present. The lag between peak 
responses in the remaining 10 subjects likely reﬂects a normal range of arterial compliance. 
T[Hb + Mb] reﬂects both skeletal muscle myoglobin and erythrocyte hemoglobin in the 
microvasculature beneath the probe. Assuming that myoglobin remains constant, any changes in 
T[Hb + Mb] must reﬂect changes in microvascular erythrocyte concentration (microvascular 
hematocrit)[14]. At rest, microvasculature hematocrit can be far lower than systemic values[38], 
a result of the Fahraeus effect and impedance to plasma entry in the capillary networks due to the 
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glycocalyx. Capillary hematocrits of 10.4%, arteriolar hematocrit of 13.9% and conduit artery 
hematocrit of 53.2% have been reported at rest in the rat[38]. 
The increase in T[Hb + Mb] during reactive hyperemia represents a temporary abatement 
of the Fahraeus effect as the hyperemic blood ﬂow and increased blood velocity in the brachial 
artery are sufﬁcient to homogenize blood ﬂow through the downstream microvasculature of the 
forearm. Hyperemia, both reactive and active, will increase micro- vascular hematocrit towards 
systemic levels[37, 56]. Hyperemia is also accompanied by an increase in the T [Hb + Mb] 
signal obtained from the NIRS device[13, 28]. As the hyperemic ﬂow in the brachial artery 
wanes, blood volume and velocity will decrease resulting in restoration of heterogeneous blood 
ﬂow through downstream vascular beds, a restoration of the Fahraeus effect, and possible 
inﬂuence of the restoration of any inﬂuence of the glycocalyx. As a result capillary hematocrit 
values will return towards baseline values, and T[Hb + Mb] will return to pre- occlusion levels. 
There are other putative mechanisms that could explain the lag time between peak 
responses of BABF and T[Hb + Mb] which are related to the broad area of interrogation of the 
NIRS probe. The hemoglobin portion of the signal reﬂects the average Hb within the arterioles, 
capillaries and venules with diameters less than 1 mm within the area of interrogation[14, 57]. 
Microvascular hematocrit is proportional to the ratio of red blood cell ﬂux to red blood cell 
velocity[37, 58]. During and in recovery from muscle contractions[58] or ischemia[59] the rate 
of change in these two measures is not the same; the change in red blood cell velocity is faster 
than the change in red cell ﬂux and varied across muscles resulting in a discrepancy between the 
changes in ﬂux (ﬂow) and hematocrit. In the present study, the volume of interrogation of the 
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NIRS probe included multiple muscles, speciﬁcally the brachioradialis, ﬂexor carpi radialis, 
ﬂexor digitorum superﬁcialis and pronator teres. It is possible that the different response rates at 
distinct levels of the microvascular tree, and the differential response rates of red blood cell ﬂux 
and velocity found in different muscles could all affect the global microvascular response within 
the tissue volume of NIRS interrogation, and therefore mechanistically underlie the differences 
in the temporal characteristics of the microvascular responses of T[Hb + Mb] and its relationship 
to BABF across individuals. 
The characteristics of the arterial tree can be described in terms of compliance (C) and 
resistance (R) where R ∗ C = τ. The 4 muscles that are within the area of interrogation of the 
NIRS probe are fed by different arterial systems. The brachioradialis is fed by the radial artery, 
the pronator teres by both the ulnar and radial arteries, while the ﬂexor digitorum superﬁcialis 
and the ﬂexor carpi radialis are both fed by the ulnar artery. Each of these arteries receives inﬂow 
from the brachial artery. These arteries (brachial, radial and ulnar) have different diameters and 
would likely have different compliance and resistance values, resulting in 3 different time 
constants[60, 61]. Thus, the lumped-parameter microvascular time constants determined here 
represent weighted integration of the blood ﬂow through all three arteries. Unfortunately, current 
technology does not permit the distinction of each of the arteries to the ﬁnal lumped-parameters. 
The microvascular rheologic responses observed here during reactive hyperemia differ 
from those reported in other studies during active hyperemia. In the rat model, there was no 
change in capillary hematocrit for approximately 20 s after the initiation of contractions; once 
hematocrit changed it did so with a biphasic temporal proﬁle[37]. In contrast, our results during 
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occlusive reactive hyperemia demonstrated an immediate, exponential increase in T[Hb + Mb], 
reﬂecting an increase in microvascular hematocrit, following cuff release. This different response 
proﬁle could be related to the absence of the muscle pump in reactive hyperemia and the 
vasodilation that exponential (both τ1 and τ2) were not inﬂuenced by ATT and support our earlier 
ﬁndings that correction for ATT is not required for purely kinetic analysis of NIRS data. In 
contrast, we found that baseline (Y0) values and both amplitude measures of T[Hb + Mb] were 
inﬂuenced by ATT (Fig. 4). We had previously shown that only those parameters associated with 
signal strength, like baseline T[Hb + Mb] and amplitude values, but not temporal parameters 
such as time constants, were inﬂuenced by ATT[13]. In our previous study we used exponential 
and sigmoidal functions to examine the temporal parameters of the oxy[Hb + Mb] and deoxy[Hb 
+ Mb] responses during PORH. In the current investigation we used a double exponential 
function to examine the temporal parameters of the T[Hb + Mb] and BABF responses during 
PORH. The current investigation showed that time constants do not require correction for ATT 
when using a double exponential function as well. 
 CONCLUSION 
In conclusion, macrovascular and microvascular responses in the forearm during reactive 
hyperemia have similar temporal proﬁles. Our results suggest that during reactive hyperemia the 
macrovascular response determines the microvascular response in the human forearm. The 
strong association between our two responses, including cross correlations, the Granger causality 
results and the correlation between τ2 values for each response suggest that the temporal 
characteristics of the conduit artery blood ﬂow are reﬂected in the downstream microvasculature. 
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Finally, our results conﬁrm that correction for adipose tissue thickness is not required when 
performing a purely temporal analysis of NIRS data. 
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Table 3-1: Subject characteristics. Data is presented as average ± SD. 
Subject characteristic N = 15 (8 males) 
Age (years) 21.4 ± 1.7 
Height (cm) 174.7 ± 9.3 
Weight (Kg) 77.5 ± 21.1 
Body mass index (Kg/m2) 23.9 ± 4.3 
Adipose tissue thickness (mm) 4.6 ± 1.6 
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Table 3-2: Correlation, cross-correlation and time displacement data between BABF and 
T[Hb+Mb] for each subject.  
Subject Correlation 
coefficient 
Cross-correlation Lag time between 
peaks (s) 
1 0.92 0.93 1 
2 0.98 0.98 0 
3 0.96 0.96 0 
4 0.93 0.94 2 
5 0.84 0.91 6 
6 0.85 0.92 6 
7 0.86 0.87 1 
8 0.96 0.96 0 
9 0.93 0.95 2 
10 0.97 0.97 0 
11 0.84 0.92 6 
12 0.92 0.95 3 
13 0.98 0.98 0 
14 0.79 0.88 7 
15 0.93 0.98 3 
Average 0.91 0.94 3.7 
SD 0.06 0.03 2.6 
Correlation coefficient represents the correlation between BABF and T[Hb+Mb] responses. 
Cross-correlation represents the correlation coefficient after accounting for lag times. Lag time 
between peaks represents the post-cuff release time displacement between T[Hb+Mb] and 
BABF. 
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Table 3-3: Temporal parameters and comparison ratios for all subjects. 
Subject τ1BABF τ2BABF τ1(T[Hb+Mb]) τ2(T[Hb+Mb]) τ2BABF/τ1BABF τ2(T[Hb+Mb])/τ1(T[Hb+Mb]) 
1 3.2 27.4 3 40.3 8.5 13.6 
2 5.4 22.3 6.6 19.8 4.1 3 
3 3.2 27.6 9.4 14.7 8.6 1.6 
4 5.9 25.7 14.7 29.7 4.4 2 
5 4.3 40.8 9.8 78.5 9.4 8 
6 4.3 16.7 13.3 20.2 3.9 1.5 
7 3 24.7 2.7 81.2 8.2 30.3 
8 5.3 13.1 4.8 14.6 2.5 3 
9 2.6 34.7 5.8 23.8 13.1 4.1 
10 3.7 34.7 4.8 60 9.3 12.4 
11 2.1 45.6 9.4 51.9 21.3 5.5 
12 6.5 18.6 13 18.6 2.9 1.4 
13 3.1 42.2 12.3 18.5 13.6 1.5 
14 3 19.3 15.1 19.2 6.4 1.3 
15 6 9 8.8 11.4 1.5 1.3 
Average 4.1
ab
 26.8 8.9
a
 33.5 7.8 6 
SD 1.4 10.9 4.2 23.5 5.2 7.8 
 
a
 Significantly faster than τ2 for each response variable, p<0.05 
b
 Significantly faster than τ1(T[Hb+Mb]) p <0.05  
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Table 3-4: ATT and non-temporal parameters. 
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Figure 3-1: Representative graph showing lag between peak values in one representative 
subject. This pattern was observed in 10 of 15 subjects. 
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Figure 3-2: Representative graph showing coincident peak values in one representative 
subject. This pattern was observed in 5 of 15 subjects. 
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Figure 3-3: Relationships among time constants for BABF and T[Hb + Mb] during PORH. 
Trendlines are shown when significant correlation existed. 
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Figure 3-4: Relationship between original (●) and corrected (Δ) baseline T[Hb + Mb] (Y0), 
A1 and A2 plotted against ATT. Solid lines indicate linear regression model for 
uncorrected-for-ATT data. Dashed lines indicate linear regression model for corrected-for-
ATT 
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Chapter 4 - The association between cutaneous and 
intramuscular microvascular measures during post-
occlusive reactive hyperemia.  
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 ABSTRACT 
The purpose of this study was to compare microvascular kinetics during reactive hyperemia 
between skeletal muscle and cutaneous tissue. Cutaneous reactivity was assessed with laser-
Doppler flowmetry. Intramuscular reactive hyperemia was assessed via two different techniques; 
single-fiber intramuscular laser-Doppler flowmetry (IMLD) was used to measure microvascular 
red blood cell flux, while near-infrared spectroscopy (NIRS) was used to measure changes in 
Total Hemoglobin+Myoglobin (T[Hb+Mb]). A double exponential function with no time delay 
was fit to each response curve and time constants (τ) for brachial artery blood flow (BABF),  
T[Hb+Mb], IMLD, and the proximal (SK1) and distal cutaneous probes (SK2) were recorded for 
both the rise from baseline to peak value (τ1) and for the return from peak to baseline values (τ2). 
Time to peak was also determined for each response. For all responses, τ1 was significantly faster 
than τ2 (p<0.001 – p=0.002). For both time to peak and τ1, BABF was significantly faster than 
T[Hb+Mb], IMLD, SK1 and SK2 (p<0.02). In turn, T[Hb+Mb] was significantly faster than 
IMLD for both time to peak (p=0.024) and τ1 (p<0.01). No differences were observed between 
all responses for τ2 (p=0.3). Finally, the temporal profile of the cutaneous reactive hyperemic 
response did not differ from that observed in the skeletal muscle via either NIRS or IMLD.  
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 INTRODUCTION 
The cutaneous microvasculature remains an appealing target for microvascular 
assessment due to its ready accessibility. It has been proposed that the cutaneous 
microvasculature could serve as model of generalized microvascular function[62]. For this to be 
true, changes in the cutaneous tissue would need to be quantitatively similar to the changes 
observed in other microvascular beds, such as skeletal muscle, in response to an intervention. 
There are several studies showing that this is not always the case. Addor et al. showed that the 
duration of reactive hyperemia was different between skin and skeletal muscle in the 
forearm[18]. Additionally, they demonstrated that aspirin administration increased the peak 
reactive hyperemic response in skeletal muscle, while in cutaneous tissue the duration of reactive 
hyperemia was reduced. Regardless of the mechanisms behind reactive hyperemia in cutaneous 
tissue and skeletal muscle, for one to serve as a surrogate of the other, the dynamic responses 
during post-occlusive reactive hyperemia (PORH) would have to show a high degree of 
symmetry.  
Near-infrared spectroscopy (NIRS) has been used for over 40 years to non-invasively 
monitor oxygen status in various tissues, including skeletal muscle [6]. Despite this long tenure, 
there is still uncertainty regarding what this technique actually measures within skeletal muscle. 
Some of this uncertainty is due to the differing abilities of the commercially available devices to 
assess oxygenation status with NIRS. The OxiplexTS (ISS, Inc., Champlain, IL) device used in 
this project is able to quantify both oxy[hemoglobin+myoglobin] (oxy[Hb+mb]) and 
deoxy[hemoglobin+myoglobin] (deoxy[Hb+Mb]). The sum of these two measurements is equal 
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to total hemoglobin + myoglobin (T[Hb+Mb]). We have previously characterized the responses 
of oxy[Hb+Mb] and deoxy[Hb+Mb] and the resultant changes in T[Hb+Mb] during post-
occlusive reactive hyperemia in the human forearm [16].  Assuming that tissue myoglobin 
remained constant, we suggested that changes in T[Hb+Mb] during PORH represented changes 
in skeletal muscle microvascular hemoglobin concentration (hematocrit), possibly due to an 
abatement of the Fahraeus effect [14, 16]. However, to date, the physiological meaning of 
changes in T[Hb+Mb] remain untested.  
Intramuscular single-fiber laser Doppler (IMLD) is an invasive technique used to 
determine blood perfusion and erythrocyte flux (flow). Recently, this technique has been used to 
assess alterations in microvascular blood flow due to pain and musculoskeletal injuries [63-66]. 
Earlier studies using this technique compared bulk blood flow and red cell flux (an index of 
microvascular blood flow) in both skeletal muscle and cutaneous tissue during reactive 
hyperemia [67, 68]. What remains unclear is the temporal relationship between changes in 
microvascular hematocrit (T[Hb+Mb]) and erythrocyte flux (IMLD) during reactive hyperemia 
in the skeletal muscle of the forearm and the overlying cutaneous tissue. In the present study, we 
combined NIRS and IMLD to investigate these relationships.   
Thus, one purpose of this investigation was to compare temporal responses between 
cutaneous and intramuscular vascular beds during PORH. We hypothesized that the time 
constants would be different in the skeletal muscle microvasculature compared to those observed 
in the cutaneous microvasculature. The second purpose of this investigation was to compare 
temporal characteristics of the reactive hyperemic responses within skeletal muscle as measured 
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with NIRS and IMLD. We hypothesized that there would be no differences between the temporal 
parameters of NIRS and IMLD during PORH.   
 METHODS 
 Subjects 
Eight males (average age 20.6±0.9 years) were recruited from the general student body at 
Kansas State University. The study was approved by the Institutional Review Board for Research 
Involving Human Subjects at Kansas State University. All subjects abstained from alcohol and 
strenuous exercise for 24 hours prior to testing. Subjects were fasted and had abstained from 
caffeine for 12 hours prior to testing. Subjects were also instructed to abstain from non-steroidal 
anti-inflammatory drugs for 24 hours.  
 Protocol 
All tests were performed between 0900-1100. Each subject underwent 3 PORH trials 
consisting of 1 minute of baseline data collection, 5 minutes of brachial artery occlusion and 3 
minutes of PORH monitoring. At least 15 minutes were allowed between trials for responses to 
return to baseline. 
 Intramuscular monitoring 
Both NIRS and IMLD flowmetry were used to evaluate reactive hyperemia within the 
skeletal muscle of the forearm. Quantitative measures of the changes in total 
hemoglobin+myoglobin (T[Hb+Mb]) were assessed with NIRS(OxiplexTS, ISS, Inc., 
Champlain, IL). With the subject supine, the NIRS probe was placed on the supinated left 
forearm over the brachioradialis and the flexor carpi radialis muscles. IMLD flowmetry was used 
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to measures changes in red cell flux within the same sampled muscle. The single fiber 
intramuscular laser Doppler probe (Periflux 5010 laser Doppler perfusion monitor, with Master 
probe 418-1 with MT A500-0 (120mm), Perimed; Jarfalla, Sweden) was placed through a 22-
gauge catheter inserted into the muscle adjacent to the NIRS probe.  Thirty minutes were allowed 
post probe insertion for restoration of baseline. We had intended to insert the intramuscular 
probe directly beneath the NIRS probe to sample the same muscle volume, but in pilot studies 
this placement scheme generated artifacts in both signals. The probe was therefore inserted just 
adjacent to the NIRS probe, but still within the same muscle tissue being monitored by NIRS, 
which eliminated the interference. Laser-Doppler results were recorded in mV.    
 Cutaneous monitoring 
Changes in cutaneous red cell flux were also assessed with laser Doppler flowmetry. Two 
integrated laser Doppler probes (Probe 413, Perimed) were placed on the forearm and secured 
with a probe holder. One was placed proximal to the NIRS probe (SK1) and one distal (SK2). As 
with the intramuscular laser-Doppler, cutaneous results were recorded in mV.  
 Brachial artery monitoring 
Total blood flow into the forearm was measured beat by beat in the brachial artery 
(BABF) via pulsed-Doppler ultrasound (GE VIVID3, GE Medical Systems). Data was stored in 
5 second intervals; vessel diameter was obtained discontinuously at the beginning of each 5 
second collection interval.  Blood flow was calculated as the velocity time integral (the distance 
in cm the blood travels per second) multiplied by cross sectional area (0.785* D
2
) to generate 
blood flow per second. All Doppler images were analyzed by the same investigator.     
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 Brachial artery occlusion 
The left arm was instrumented with a pressure cuff (SC12D) attached to a rapid inflator 
(E20 Rapid Cuff Inflator) with a dynamic air source (AG101) (for both, Hokanson, Bellevue, 
WA), which is capable of cuff inflation in less than 0.5 s. Following 1 minute of baseline data 
collection the 5-minute occlusion period was initiated by inflation of the cuff to suprasystolic 
pressure (250mmHg).  
 Continuous blood pressure monitoring 
Continuous blood pressure monitoring on the right arm was carried out via 
photoplethysmography (NexfinHD; BMEYE,(Amsterdam, The Netherlands). These readings 
were confirmed via periodic automated blood pressure monitoring (S5 Light Monitor; Datex-
Ohmeda, GE Healthcare; Madison,WI, USA).  
 Data management 
All data were collected at 1Hz and stored for offline analysis. The NIRS system uses its 
own proprietary software, OxiTS (ISS, Inc.), for data management. The laser Doppler data were 
recorded using Windaq signal processing software (Dataq Instruments, Akron, OH). Brachial 
artery blood flow (BABF) data was calculated beat by beat, imported into Sigmaplot 10 and 
interpolated to 1Hz. We have previously reported that correction of NIRS data for adipose tissue 
thickness is not required when performing a temporal analysis,[16] therefore no correction for 
ATT was performed on our NIRS data. All red blood cell flux values obtained through laser-
Doppler flowmetry were divided by mean arterial pressure to generate measures of intramuscular 
and cutaneous vascular conductance with units of mV/mmHg. T[Hb+Mb] data from 2 subjects 
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were excluded from the analysis because of significant accumulation of T[Hb+Mb] during the 5-
min cuff occlusion, which eliminated the overshoot during PORH. 
 Statistical analysis 
All subjects underwent 3 trials of the PORH protocol. Data from the 3 trials were time 
aligned and averaged. For one subject, only two trials were used due to equipment failure. A 
double exponential function (Equation 1) with no time delay was fit to each response curve and 
time constants (τ) for BABF, T[Hb+Mb], IMLD, SK1 and SK2 were determined for both the rise 
from baseline to peak value (τ1) and for the return from peak to baseline values (τ2). Time to 
peak was also determined for each response. Also recorded were baseline values (Y0) and two 
amplitude values (A1 and A2) corresponding to the amplitude of the rise to peak and the 
subsequent return towards baseline from peak, respectively. 
 Equation 1:  Y= Y0+A1*(1-e
(-t/tau
1
)
) - A2*(1-exp
(-t/tau
2
)
)      
Comparisons among temporal responses were made with one way repeated measures analysis of 
variance. Student-Newman-Kuels post-hoc analysis was used where appropriate to look for 
individual differences in means. Individual paired t-tests with Bonferonni correction were 
performed where group differences were masked by missing data and/or high variance.  
 RESULTS 
Figures 1 and 2 illustrate a complete protocol with intramuscular and cutaneous responses in the 
same subject. The 5-minute occlusion period was followed by cuff release and PORH monitoring 
until values returned to baseline (approximately 3 minutes).  Figure 3 shows BABF, T[Hb+Mb] 
and IMLD responses during PORH in the same subject. Table 1 shows the time constants for the 
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on (τ1) and off (τ2) kinetic responses for all variables of interest. For all responses, τ1 was 
significantly faster than τ2 (p<0.001 – p=0.002). 
 τ1 and Time to Peak 
The overall responses for τ1, (Table1) and Time to Peak (Table 2) were similar. BABF was 
significantly faster than the other 4 responses (p<0.02). In turn, T[Hb+Mb] was significantly 
faster than IMLD for both τ1 (p<0.01) and time to peak (p=0.024), which was not different from 
the two cutaneous measures.  
  τ2 
No significant differences were observed between any variables (p=0.30).  
 DISCUSSION 
The first main finding of this investigation was that, contrary to our first hypothesis,  
there were no significant differences in the temporal parameters of PORH between skeletal 
muscle (both NIRS and IMLD) compared with the cutaneous microvasculature. In contrast to our 
second hypothesis, significant differences were observed in the temporal parameters measured 
within skeletal muscle via two different techniques (NIRS and IMLD).     
Holowatz et al. suggested that the cutaneous microvasculature can be used as an analog 
for total body microvascular function[62]. If true, this would predict that temporal responses to 
PORH within the cutaneous microvasculature would be similar to those observed in the skeletal 
muscle microvasculature. In the present  study, neither T[Hb+Mb] nor IMLD responses were 
significantly different from those observed in the cutaneous microvasculature, consistent with the 
suggestions of Holowatz et al.  
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The validity of using the cutaneous microvasculature as a surrogate for coronary[69] and 
skeletal muscle[70, 71] microvascular beds has been questioned [72]. Ijzerman et al. stated that 
the assessment of intramuscular, cardiac and renal microvascular reactivity would be most 
relevant from a pathological standpoint, but that this would require invasive and complicated 
techniques [73]. Further, both Wilkins[74] and Edvinsson and Andersson[75] noted the need for 
direct comparisons between the cutaneous and skeletal muscle microvasculatures before these 
tissues could be used interchangeably. Our laboratory has previously suggested that there could 
be differences between the dynamic responses of the cutaneous and skeletal muscle circulations 
during PORH[71]. The current study resolves the problem identified by Ijzerman and colleagues 
by establishing that a simple, non-invasive technique (NIRS) does provide reliable intramuscular 
assessments. Further, by directly comparing the cutaneous and skeletal muscle microvasculature 
responses, we were able to establish that the cutaneous and skeletal muscle microvascular 
temporal responses during PORH were not significantly different, using LDF. Although the 
mechanisms underlying cutaneous versus skeletal muscle PORH may differ, our data suggest the 
resulting temporal responses are similar.  
Neither changes in T[Hb+Mb] nor intramuscular vascular conductance (IMLD) are true 
measures of microvascular blood flow. In turn, differences between the two techniques may 
account for the observed differences in temporal profiles between these measurements. It is 
currently unclear what the underlying mechanism is for the T[Hb+Mb] changes during PORH. 
We have previously suggested that T[Hb+Mb] is related to microvascular hematocrit [13]. 
Assuming that tissue myoglobin remains constant during our protocol, the transient increase in 
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T[Hb+Mb] following cuff release must come from increases in hemoglobin concentration 
(hematocrit) within the skeletal muscle microvasculature [14]. In contrast, laser-Doppler 
flowmetry examines the degree of Doppler shift of moving red blood cells.  
The relationships among capillary hematocrit, RBC flux and RBC velocity have been 
examined in skeletal muscle during the transitions from rest to contraction and from contraction 
to recovery.[37, 58] These authors established that capillary hematocrit is proportional to the 
ratio of RBC Flux (flow) to RBC velocity. Kindig et al [37]. found that RBC velocity 
immediately increased to steady state following exercise onset,  while flux increased in 2 phases; 
a rise to a plateau at 12-20 seconds followed by a secondary rise to steady state values. Capillary 
hematocrit did not significantly increase until 18 seconds after the initiation of contractions; this 
increase in hematocrit coincided with the onset of arteriolar dilation due to metabolic feedback. 
During recovery, Ferreria et al. found little or no change in RBC flux or velocity immediately 
following cessation of contractions [58]. Both flux and hematocrit dropped significantly at 5 
seconds into recovery, while velocity did not change for 15-20 seconds. Both Kindig et al. [37] 
and Ferreria et al. [58] report little association between changes in hematocrit and changes in 
RBC velocity. Under both exercise and recovery conditions, flux changed to a greater extent than 
did velocity and was the determining factor in changes in hematocrit.   
The results of the present study during PORH do not resemble the temporal profiles 
described for exercise. Both hematocrit (T[Hb+Mb]) and flux (IMLD) responses showed an 
immediate, exponential rise to peak upon cuff release. There was no time delay in either 
response, likely because at cuff release arterioles were already vasodilated due to the 5 minutes 
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of ischemia. Although this investigation did not measure microvascular RBC velocity, for an 
increase in hematocrit to be observed, the increase in flux would need to be greater than the 
increase in velocity and/or velocity must decrease as flux increases. Either scenario would result 
in increased hematocrit. House and Liposky [59] found that red cell velocity decreased as 
capillary hematocrit increased during PORH, likely due to increased blood viscosity as 
hematocrit increased [76]. Humeau et al.,modeled laser Doppler flux responses during reactive 
hyperemia in a theoretical, simple microvessel [77]. Their models showed that red cell velocity 
achieved a steady state rapidly (within .001 s) upon cuff release, and that the increase in flux was 
due to an increasing number of RBCs in the area of interrogation due to vasodilation [78].    
 Active and reactive hyperemia have different causative mechanisms. In active hyperemia, 
as with exercise, the muscle pump produces a rapid increase in muscle blood flow [79]. Within 
7-15 seconds of the start of exercise, vasodilators, such as nitric oxide and prostacyclin jointly 
induce vasodilation and regulate blood flow [37, 79-81]. These disparate mechanisms produce 
the two phase response observed by Kindig et al. [37] in the transition from rest to muscle 
contraction. In contrast, with reactive hyperemia of the forearm, brachial artery occlusion causes 
ischemia in the downstream vasculature. The resulting hypoxemia and metabolic dilators such as 
adenosine and H+, induce arteriolar dilation during the period of occlusion [82]. Previous 
authors have also suggested a role for both prostanoids (PGE2, PGI2 and Thromboxane) [3, 43, 
83], nitric oxide [84] and endothelial hyperpolarization [85] in the reactive hyperemic response 
in skeletal muscle.  These systems have a high degree of interaction and redundancy between 
them which causes difficulty in determining which has the greatest effect on PORH [81, 86-88]. 
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Upon cuff release, first conduit artery and then microvascular blood flow overshoots resting, pre-
cuff levels. With the increase in brachial artery blood flow, downstream microvascular flow will 
be homogenized, leading to reversal of the Fahraeus effect and a subsequent increase in red cell 
flux and velocity leading to increased shear stress on the vascular endothelium, causing flow-
mediated dilation [89]. The reactive hyperemia is temporary; as metabolic dilators are flushed 
away, the arterioles will return to their resting diameters. Brachial artery blood flow returns to 
baseline and the Fahraeus effect is reinstated, microvascular blood flow heterogeneity returns 
and red cell flux and eventually velocity will return to baseline [90]. As flux returns to normal, 
microvascular hematocrit (and T[Hb+Mb]) will also return to baseline.   
Changes in total limb blood flow, as during post-occlusive reactive hyperemia, of 
forearm skeletal muscle has historically been measured with strain gauge plethysmography [17, 
91, 92]. One limitation of this technique is that the initial 3-5 seconds of data cannot be 
captured[18]. Both NIRS and IMLD overcome this limitation by collecting data continuously. 
Neither of these techniques measures flow per se; T[Hb+Mb] reflects changes in microvascular 
hematocrit while IMLD measures changes in RBC flux [16, 77]. The invasive nature of the 
IMLD probe compared with the non-invasive nature of the NIRS probe suggests that NIRS is the 
better choice for future evaluation of skeletal muscle microvasculature reactivity. Both the NIRS 
and IMLD systems sample from arterioles, capillaries and venules [15, 93]. A significant 
difference between the two techniques is the area of interrogation. The IMLD microtip probe 
samples within a small area of interrogation (roughly 1 mm
3
) directly in front of the probe tip 
[68]. In contrast, the OxiplexTS (NIRS) is able to penetrate to a depth of 17.5mm, and across 
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several muscles (brachioradialis, flexor carpi radialis,flexor digitorum superficialis and pronator 
teres); as such, NIRS provides a more generalized measure of PORH in the forearm [16]. The 
IMLD probe was inserted directly into the sampled muscle, parallel to the NIRS probe so that 
both devices were monitoring the same tissue. Microvascular blood flow demonstrates marked 
heterogeneity, thus, it is possible that the differences in the temporal profiles of NIRS versus 
IMLD result, in part, from sampling different regions within the skeletal muscle 
microvasculature [31].  The invasive nature of the IMLD probe combines with the limited area of 
interrogation suggests that NIRS is the better choice for future evaluation of skeletal muscle 
microvasculature reactivity.  
Two of our eight subjects demonstrated accumulation of T[Hb+Mb] during the cuff 
occlusion period. We are confident that our brachial artery cuff completely occluded the artery  
and that flow into the forearm was zero as confirmed by loss of radial pulse and continuous 
measurement of brachial artery blood flow. Therefore, the accumulation of the T[Hb+Mb] signal 
over the course of the 5 minute occlusion period was likely caused by redistribution of red blood 
cells already within the forearm vasculature. These subjects may have experienced increased red 
blood cell accumulation in the venules during occlusion as has been previously reported [59]. 
Again, NIRS can only detect changes in vessels smaller than 1mm in diameter [14, 15] so this 
accumulation may represent movement of red blood cells from larger diameter vessels where 
they would be undetectable by NIRS into smaller vessels where they could be detected [94]. This 
movement may be facilitated by both the pressure gradient and difference in vessel compliance 
from the arterial to the venous vascular compartment.  
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T[Hb+Mb] accumulation is a major obstacle in the expansion of NIRS use in PORH 
research. In this investigation, 25% of our subjects experienced such accumulation. In a previous 
study from our lab, 3 of 26 (12%) participants demonstrated T[Hb+Mb] accumulation. To 
increase the utility of NIRS in the assessment of vascular reactivity within skeletal muscle, 
techniques must be developed to decrease the incidence of accumulation. One possible approach 
may be to add a wrist cuff to the protocol, as was traditionally done with strain gauge 
plethysmography, to exclude the hand circulation, thus forming a completely sealed forearm 
compartment which may minimize red cell redistribution across AV anastomoses between the 
distal ends of the radial and ulnar arteries and veins in the distal wrist and proximal hand[95]. 
However, use of such a cuff could alter the reactive hyperemic response in the forearm and may 
alter relationships between skeletal muscle, cutaneous and conduit artery responses during 
PORH in the forearm[96].   
 CONCLUSION 
In conclusion, no differences in temporal profiles were observed between cutaneous and 
intramuscular measures, either by NIRS or IMLD, during PORH in the forearm.  These results 
suggest that, at least in the human forearm and during a purely temporal analysis of PORH, the 
cutaneous microvasculature can serve as a surrogate for the skeletal muscle microvasculature. 
Significant differences were found between the temporal parameters measured within skeletal 
muscle using NIRS and IMLD. These results suggest that technical and physiological differences 
between NIRS and IMLD can result in discrepancies in measurements within the same vascular 
bed.      
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Table 0-1: Time constants for all variables. 
BABF- Brachial artery Blood Flow 
T[Hb+Mb]- Total Hemoglobin+myoglobin 
IMLD – Intramuscular Laser Doppler 
SK1- Proximal skin probe 
SK2 – Distal Skin probe 
*Significantly longer than BABF (p<0.001) 
‡Significantly longer than T[Hb+Mb] (p<0.01) 
 
 
 
 
 
 
 
 
 
 Conduit Artery Intramuscular microvasculature 
Cutaneous 
Microvasculature 
 
BABF
τ1 
BABF
τ2 
T[Hb+Mb]
τ1 
T[Hb+Mb]
τ2 
IMLD
τ1 
IMLD
τ2 
SK1τ
1 
SK1τ
2 
SK2τ
1 
SK2τ
2 
Averag
e 1.4 30.7 4.5* 57.6 12.5*‡ 40.8 10.5* 41.6 10.8* 48.6 
SD 0.5 18.4 1.1 24.6 4.4 41.0 11.8 8.8 10.2 13.0 
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Table 0-2: Time to peak (s) for all variables. 
 BABF T[Hb+Mb] IMLD SK1 SK2 
Average 6.6 13.2* 23.4‡* 22.0* 19.9* 
SD 3.1 4.0 9.1 17.2 11.6 
 
*Significantly longer than BABF (p≤0.01) 
‡Significantly longer than T[Hb+Mb] (p=0.02)  
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Figure 0-1: Responses for intramuscular laser Doppler (IMLD) and Total [Hb+Mb] from 
NIRS in a representative subject. Included are baseline, 5-minute cuff occlusion and PORH 
response to cuff release. Cuff release occurs at 320 seconds. 
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Figure 0-2: Laser-Doppler responses for cutaneous PORH in the same subject as Figure 1. 
Included are baseline, 5-minute cuff occlusion and PORH response to cuff release. Cuff 
release occurs at 320 seconds. 
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Figure 0-3: BABF, T[Hb+Mb] and IMLD PORH responses in a representative subject. Time 0 
represents cuff release.  
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Chapter 5 -Ibuprofen alters the initial post-occlusive 
reactive hyperemic response in skeletal muscle, but not 
cutaneous tissue, in the human forearm 
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 ABSTRACT 
The purpose of this study was to compare the effects of 1200 mg of oral ibuprofen, a non-
selective inhibitor of cyclooxygenase, on the post-occlusive reactive hyperemic response in 
skeletal muscle and cutaneous tissue.  Skeletal muscle responses were measured as changes in 
T[Hb+Mb] with near-infrared spectroscopy. Cutaneous vascular conductance was measured with 
laser Doppler flowmetry. A double exponential function with no time delay was fit to each 
response curve and time constants (τ) for brachial artery blood flow (BABF),  T[Hb+Mb], and 
the proximal (SK1) and distal cutaneous probes (SK2) were recorded for both the rise from 
baseline to peak value (τ1) and for the return from peak to baseline values (τ2). For all responses, 
τ1 was faster than τ2 (p<0.001). Time to peak and total hyperemic responses were also 
determined for each signal. Inhibition of prostaglandin production with 1200 mg of ibuprofen 
slowed the initial changes for T[Hb+Mb] within skeletal muscle (τ1 (p=0.014) and time to peak 
(p=0.002), but had no effect on τ2 . No effects were observed in cutaneous or conduit artery 
responses. Ibuprofen had no effect on total hyperemic response, measured as area under the 
response curve, in any tissue. These results suggest that vasodilator prostaglandins play a role in 
the microvascular hematocrit response within the skeletal muscle, but not in cutaneous tissue 
immediately cuff release following ischemic cuff occlusion.  
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 INTRODUCTION 
Post occlusive reactive hyperemia (PORH) is a temporary increase in blood flow and 
velocity above resting levels occurring after a period of ischemia. As a result of brachial artery 
occlusion, dilation of downstream arterioles occurs due to the presence of local metabolites, such 
as adenosine[97] and vasodilator prostaglandins.[17] When the occlusion is released, the 
decreased vascular resistance results in a transient increase in blood flow.  This increase in blood 
flow and velocity serves as the stimulus for flow-mediated dilation of the conduit artery.[1, 5] 
The reactive hyperemia test procedure in the forearm is simple to perform compared with 
measurements of flow-mediated dilation (FMD), and recent studies suggest that reactive 
hyperemia is a more predictive measure of cardiovascular disease than is FMD itself.[5, 98]   
Metabolism of arachidonic acid by either isoform of the cyclooxygenase enzyme (COX) 
leads to the formation of several vasoactive prostanoids including prostaglandin H2 (PgH2).[99] 
In endothelial cells, a potent vasodilator, prostacyclin (PgI2), is formed from PgH2 via the action 
of prostacyclin synthase. In platelets, thromboxane A2 (a vasoconstrictor) is formed from PgH2 
via the actions of thromboxane synthase.[100] Non-steroidal anti-inflammatory drugs (NSAIDs), 
like ibuprofen, are potent inhibitors of prostaglandin synthesis due to its non-selective inhibition 
of COX.[20] Many studies have examined the effects of non-steroidal anti-inflammatory drugs 
(NSAIDS) on reactive hyperemia in both skeletal muscle and cutaneous tissue. In skeletal 
muscle NSAIDS produce a blunted reactive hyperemic response.[3, 17-19] Specifically, these 
authors observed a decrease in peak and total hyperemic response to a 5-minute ischemic cuff 
occlusion.[17] [3] Later studies found that ibuprofen altered peak, but not total, hyperemic 
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flow.[18, 19]  In cutaneous tissue there is no strong evidence to suggest that prostanoids, either 
vasodilatory [101, 102] or vasoconstrictive, [83] contribute to PORH.[103]  
Near-infrared spectroscopy (NIRS) has been used to non-invasively monitor oxygen 
status in various tissues, including skeletal muscle, for over 40 years.[6] We have previously 
characterized the responses of oxy[Hb+Mb] and deoxy[Hb+Mb] and the resultant changes in 
total hemoglobin + myoglobin (T[Hb+Mb]) during post-occlusive reactive hyperemia in the 
human forearm.[13, 16]  We suggested that changes in T[Hb+Mb] represent changes in skeletal 
muscle microvascular hematocrit, linking the increased brachial artery blood flow during PORH 
with an abatement of the Fahraeus effect and increased microvascular hematocrit [16]. Assuming 
that tissue myoglobin remains constant during PORH, the transient increase in T[Hb+Mb] 
following cuff release must come from changes in hemoglobin concentration (hematocrit) within 
the skeletal muscle microvasculature.[14]  
Therefore, the purpose of this investigation was to determine the effects of prostaglandin 
inhibition on the temporal parameters of the overall reactive hyperemic response as brachial 
artery blood flow, microvascular hematocrit as T[Hb+Mb], as measured with NIRS, and 
cutaneous vascular conductance, as measured with laser Doppler flowmetry (LDF), in the 
forearm. We hypothesized that prostaglandin inhibition would alter the reactive hyperemic 
response to a 5-minute ischemic cuff occlusion in skeletal muscle while having no effect on 
cutaneous PORH.    
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 METHODS 
 Subjects 
Eight males (average age 20.6±0.9 years) were recruited from the general student body at 
Kansas State University. The study was approved by the Institutional Review Board for Research 
Involving Human Subjects at Kansas State University. Subjects were fasted and instructed to 
abstain from alcohol, strenuous exercise and NSAID use for 24 hours and caffeine for 12 hours 
prior to testing.  
 Protocol 
All tests were performed between 0900-1100. Subjects were administered 1200 mg of 
ibuprofen or a placebo 60-90 minutes prior to testing; they received the other treatment on their 
subsequent visit. Ibuprofen was chosen as the NSAID with the greatest effect on PORH.[3] 
When taken orally, peak values of ibuprofen appear in blood plasma within 60-120 minutes.[104, 
105] Each subject underwent 3 PORH trials of the non-dominant arm consisting of 1 minute of 
baseline data collection, 5 minutes of brachial artery occlusion and 3 minutes of PORH 
monitoring. At least 15 minutes were allowed between trials for responses to return to baseline. 
 Intramuscular monitoring 
NIRS was used to evaluate T[Hb+Mb] changes within the skeletal muscle of the forearm. 
Changes in T[Hb+Mb], are thought to be related to microvascular hematocrit.[14] With the 
subject supine, the NIRS probe (OxiplexTS, ISS, Inc., Champlain, IL) was placed on the 
supinated non-dominate forearm over the brachioradialis and the flexor carpi radialis muscles. 
The OxiplexTS provides quantitative measures of T[Hb+Mb] in µM.  
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 Cutaneous monitoring 
Changes in cutaneous red cell flux were assessed with laser Doppler flowmetry. Two 
integrated laser Doppler probes (Probe 413, Perimed) were placed on the forearm and secured 
with a probe holder. One was placed proximal to the NIRS probe (SK1) and one distal (SK2). 
Results were recorded in mV.  
 Brachial artery monitoring 
Total blood flow into the forearm was measured, beat by beat, in the brachial artery 
(BABF) via pulsed-Doppler ultrasound (GE VIVID3, GE Medical Systems). Data was stored in 
5 second intervals; vessel diameter was obtained discontinuously at the beginning of each 5-
second collection interval.  Blood flow was calculated as the velocity time integral (the distance 
in cm the blood travels per second) multiplied by cross sectional area (0.785* D
2
) to generate 
blood flow per second. All Doppler images were analyzed by the same investigator.     
 Brachial artery occlusion 
The non-dominant upper arm was instrumented with a pressure cuff (SC12D) attached to 
a rapid inflator (E20 Rapid Cuff Inflator) with a dynamic air source (AG101) (for both, 
Hokanson, Bellevue, WA). Following 1 minute of baseline data collection the 5-minute 
occlusion period was initiated by inflation of the cuff to suprasystolic pressure (250mmHg) in 
less than 0.5 s.  
 Wrist occlusion 
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All subjects were fitted with a standard blood pressure cuff at the wrist. This cuff was 
inflated to a suprasystolic pressure 60 seconds prior to the start of each trial to seal the forearm 
and minimize the influence of the palmar arches anastomoses on microvascular blood flow.[21]  
 Continuous blood pressure monitoring 
Continuous blood pressure monitoring on the dominant arm was carried out via 
photoplethysmography (NexfinHD; BMEYE,(Amsterdam, The Netherlands). These readings 
were confirmed via periodic automated blood pressure monitoring (S5 Light Monitor; Datex-
Ohmeda, GE Healthcare; Madison,WI, USA).  
 Data management 
NIRS and IMLD data were collected at 50Hz and 1Hz, respectively, and stored for 
offline analysis. The NIRS system uses its own proprietary software, OxiTS (ISS, Inc.), for data 
management. Cutaneous data were recorded using Windaq signal processing software (Dataq 
Instruments, Akron, OH). Brachial artery blood flow data was calculated beat by beat. BABF 
data was imported into Sigmaplot 10 and interpolated to 1HZ. We have previously reported that 
correction of NIRS data for adipose tissue thickness is not required for analysis of time 
constants.[16] The remaining NIRS parameters (amplitude and baseline) were corrected for 
adipose tissue thickness.[16] All red blood cell flux values obtained through laser-Doppler 
flowmetry were divided by mean arterial pressure to generate measures of  cutaneous vascular 
conductance (CVC) with units of mV/mmHg.   
 Data Processing 
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All subjects underwent 3 trials of the PORH protocol. Data from the 3 trials were time 
aligned to cuff release and averaged. A double exponential function (Equation 1) with no time 
delay was fit to each response curve (BABF, T[Hb+Mb], SK1 and SK2) and time constants (τ) 
for each were determined for both the rise from 
 
Equation 1:  Y= Y0+A1*(1-e
(-t/tau
1
)
) - A2*(1-exp
(-t/tau
2
)
)      
 
baseline to peak value (τ1) and for the return from peak to baseline values (τ2). Time to peak was 
also determined for each response. Also recorded were baseline values (Y0) and two amplitude 
values (A1 and A2) corresponding to the amplitude of the rise to peak and the subsequent return 
towards baseline from peak, respectively. Area under the curve (AUC) for each hyperemic 
response was calculated using equation 2. Baseline (pre-occlusion) values for each response 
were multiplied by the duration of the hyperemic response following cuff release; this value was 
subtracted from calculated AUC to calculate total hyperemic response.   
 
Equation 2: Total Hyperemic Response = AUC - (baseline values*hyperemic duration) 
 
 Statistical analysis 
Comparisons among time constants and AUC were made with one way or two way 
repeated measures analysis of variance. Student-Newman-Kuels post-hoc analysis was used, 
where appropriate, to look for individual differences in means. Individual paired t-tests with 
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Bonferonni correction were performed where group differences were masked by missing data 
and/or high variance. Associations among time constants, time to peak and AUC were evaluated 
using a Pearson product moment correlation with Bonferroni correction.    
 RESULTS 
Figure 1 shows data from a complete protocol in cutaneous tissue as measured with laser 
Doppler flowmetry and includes a baseline period followed by a 5-minute cuff occlusion of the 
brachial artery, cuff release and the hyperemic response. Figure 2 shows microvascular 
hematocrit changes during PORH under both treatment conditions with the amplitude and 
baseline parameters labeled. For each tissue assessed, and regardless of treatment, τ1 was faster 
than τ2 (p<0.001).  
Table 1 shows time constants for the initial rise to peak (τ1) and for the return to rest from 
peak (τ2) for each response. For τ1, ibuprofen administration resulted in a longer time constant 
(p=0.014) for T[Hb+Mb]. No differences were observed in τ2 (p=0.2). Ibuprofen had no effect on 
temporal parameters of reactive hyperemia measured in the cutaneous microvasculature or the 
brachial artery. Recovery kinetics (τ2) were significantly faster for BABF than for T[Hb+Mb] 
and cutaneous measures (p<0.001). Table 2 shows time to peak and total hyperemic response, 
while Table 3 shows baseline and amplitude values for each response; all NIRS amplitude 
variables were corrected for adipose tissue thickness as described previously.[16]  Time to peak 
was increased significantly (p=0.002) by ibuprofen administration for T[Hb+Mb], but not for 
cutaneous microvasculature or the conduit artery responses. Prostanoid inhibition had no effect 
on AUC, baseline or either amplitude in any response.  
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Significant associations were found among time constants, time to peak and total 
hyperemic response for T[Hb+Mb], cutaneous and conduit artery responses. For T[Hb+Mb], τ1 
(r=0.78, p=0.02), time to peak (r=0.86, p=0.005) and total hyperemic response (r=0.77,p<0.025) 
were significantly correlated between treatment conditions. Also in T[Hb+Mb], τ1  was 
correlated with time to peak  under the effects of ibuprofen (r=0.85, p=0.007), but not while 
untreated (r=.075, p=0.03). In cutaneous tissue, time to peak was correlated across treatment 
conditions in the distal skin probe (r=0.81, p=0.02), but not the proximal (p>0.025). Also for the 
distal skin probe, τ1 was correlated with time to peak under the effects of ibuprofen (r=0.86, 
p<0.001) and under placebo (r=0.83, p=.012). In the brachial artery total hyperemic response 
(r=0.93, p<0.001) there was a significant correlation between treatment conditions. Neither τ1 
nor τ2 was correlated with AUC within any signal.             
 DISCUSSION 
To our knowledge, this study is the first to examine the effects of prostaglandin inhibition 
with NSAIDS on microvascular hematocrit (T[Hb+Mb]) during PORH  with NIRS. In support of 
our hypothesis, prostaglandin inhibition with 1200 mg of ibuprofen altered temporal parameters 
of the microvascular hematocrit response in skeletal muscle, resulting in longer τ1 time constant 
and time to peak in T[Hb+Mb] compared to placebo; τ2 was unchanged.  As expected, 
prostaglandin inhibition produced no changes in time constants, total hyperemic response, time 
to peak or peak response during PORH in cutaneous tissue. These results suggest that 
prostaglandin induced vasodilation during the 5-minute period of ischemic occlusion plays a role 
in the initial changes in microvascular hematocrit within skeletal muscle, but not within 
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cutaneous tissue, upon cuff release. Our findings of longer time constants during PORH for 
T[Hb+Mb] following NSAID administration  agree with the results of previous authors who 
found blunted PORH following the administration of NSAIDS.[3, 17-19] In addition, our novel 
technique, using NIRS, highlighted differences between our findings and previously reported 
results. Earlier studies observed a decrease in both peak and total hyperemic response to a 5-
minute ischemic cuff occlusion following NSAID administration.[17] [3] Later studies found 
that ibuprofen altered peak response, but not total hyperemic flow.[18, 19]  In the current study, 
prostaglandin inhibition did not alter baseline, peak response (A1), or total hyperemic response 
(AUC) in any variable. Only τ1 and time to peak for T[Hb+Mb] was increased by ibuprofen.   
The differences between our findings and those reported by previous authors could be 
due to methodological differences. PORH assessment in the forearm has commonly been 
performed via strain gauge plethysmography (SGP) [21] with results reported as total hyperemic 
response. One limitation of SGP  is the loss of the first several seconds of the reactive hyperemia 
response,[21] precisely when we observed differences in T[Hb+Mb] within the skeletal muscle 
microvasculature  of the forearm. The loss of the initial seconds of data could alter the calculated 
AUC values and decrease the accuracy of this technique compared to the continuous assessment 
of T[Hb+Mb] with NIRS. SGP also calculates blood flow as a function of a change in volume in 
a limb and is not able to distinguish between skeletal muscle and cutaneous tissue. Our results 
show that the effects of ibuprofen administration differ between skeletal muscle and cutaneous 
microvascular beds during PORH and suggests that earlier studies where ibuprofen blunted 
reactive hyperemia, as measured with SGP, could have been reflective of changes within the 
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skeletal muscle microvasculature alone.  These results would suggest that an analysis of the 
kinetics of the T[Hb+Mb] response, as was performed in this investigation, is a more sensitive 
measure than a traditional assessment of total hyperemic response during PORH with SGP.   
 Previous authors have reported mixed findings on the effects of prostanoid inhibition on 
reactive hyperemia in cutaneous tissue using various routes of different NSAIDs (oral[18, 103, 
106, 107], rectal[17, 108], intravenous[103], intradermal injection,[109] microdialysis [101]). 
Effects of NSAID administration on cutaneous reactive hyperemia ranged from a blunted 
response, [17, 18, 107-109] no effect,[103, 106] to increased response.[101]  It is likely that 
some of these differences can be explained by the differing potency of the NSAIDS employed[3] 
and the different routes of administration. It is also possible that our dosage of ibuprofen was not 
sufficient to elicit prostanoid inhibition in the cutaneous tissue of our subjects.  Previous research 
has shown that ibuprofen is the NSAID with the greatest impact on PORH and our chosen 
dosage of 1200 mg matched or exceeded previously used dosages[3, 19] which altered reactive 
hyperemia. However, these studies did not examine reactive hyperemia in muscle and cutaneous 
tissue separately; they used SGP. The one study which did examine the effects of ibuprofen 
(800mg) on cutaneous reactive hyperemia using LDF found no effect.[106] Concentrations of 
ibuprofen in skin and muscle tissue after oral dosing have been compared with mixed 
results.[110, 111] Tedeger et al.[110] found similar levels of ibuprofen in cutaneous and muscle 
tissue after oral dosing with 800 mg, however Dominkus et al.[111] showed that concentrations 
were lower in cutaneous tissue following oral dosing with 1200 mg. It is possible that we would 
have seen a blunted response in cutaneous flux with the use of a different NSAID. 
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Ibuprofen had no impact on the recovery kinetics (τ2) of any response. Time constants for 
BABF were significantly faster than for T[Hb+Mb] and both cutaneous measures. This is 
possibly due to microvascular compliance where the hyperemic flow would be stored in the 
compliant vascular bed; additional time is required for blood to leave the system resulting in a 
longer time constant.[112] It is also possible that recovery kinetics were not altered due to 
redundant vasodilator systems that are present in the forearm such as nitric oxide and inwardly 
rectifying potassium (KIR) channels and Na+/K+-ATPase.[85] It is possible that once flow 
resumed, shear induced release of nitric oxide compensated for the lack of prostaglandin 
production during the ischemic period.[113] . These statements would only be true if T[Hb+Mb] 
is an analog of microvascular flow. However, we have previously posited that T[Hb+Mb] is 
related to microvascular hematocrit, not flow.[13]  
Previous authors established that capillary hematocrit is proportional to the ratio of RBC 
flux (flow) to RBC velocity.[37, 58] Kindig et al.[37] found that RBC velocity immediately 
increased to steady state following exercise onset,  while flux increased in 2 phases; a rise to a 
plateau at 12-20 seconds followed by a secondary rise to steady state values. Capillary 
hematocrit did not significantly increase until 18 seconds after the initiation of contractions; this 
increase in hematocrit coincided with the onset of arteriolar dilation due to metabolic feedback. 
In a previous investigation using both an intramuscular laser Doppler probe to measure flux and 
a NIRS probe to measure T[Hb+Mb], we observed skeletal muscle microvascular hematocrit and 
RBC flux increase exponentially upon cuff release and speculated that this rapid increase was 
due to the arteriolar vasodilation induced by a 5-minute ischemic cuff occlusion.[17] In the 
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current study, it is likely that inhibition of prostanoid formation by ibuprofen during ischemic 
conditions decreased the degree of arteriolar vasodilation achieved during ischemia, resulting in 
a decreased volume of erythrocytes in the area of interrogation as reflected by the blunted 
T[Hb+Mb] signal under treatment conditions but not placebo.  
In healthy blood vessels, prostacyclin (PGI2), a vasodilator prostanoid which inhibits 
platelet activation, is the primary prostanoid produced.[114] Thromboxane A2 has opposite 
actions to prostacyclin, leading to platelet aggregation and vasoconstriction.  There is a shift 
from prostacyclin production towards thromboxane A2 during periods of ischemia[83] and in 
patients with atherosclerotic cardiovascular disease, diabetes mellitus, pulmonary fibrosis and 
hypertension, peripheral artery disease, smokers and the elderly.[86, 115-118] Pasce et al.[83] 
proposed that antagonizing the thromboxane prostanoid receptor would enhance post-ischemic 
vasodilation; the antagonist agent (S18886) had no effect in healthy, young subjects. However, 
when administered to heart disease patients, this same agent improved endothelial function and 
reactive hyperemia.[87] It is likely that our results would have been markedly different in a 
clinical or aged population as ibuprofen induced  inhibition of thromboxane A2 production 
decreased vasoconstriction resulting in enhanced vasodilation and increased T[Hb+Mb] 
responses following cuff release.          
 Accumulation of T[Hb+Mb] During Occlusion 
In two previous investigations in our lab between 12% and 25% of our subjects 
experienced significant accumulation of T[Hb+Mb] such that upon cuff release there was no 
overshoot during PORH. NIRS can only detect changes in vessels smaller than 1mm in 
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diameter[14, 15] so this accumulation may represent movement of red blood cells from larger 
diameter vessels where they would be undetectable by NIRS into smaller vessels where they 
could be detected, driven by the pressure gradient from artery into capillaries and then into 
venules [94]. It could also represent vasodilation of the microvasculature under ischemic 
conditions leading to increased hematocrit.    
 In our current investigation this phenomenon was not observed in any of our 48 PORH 
trials. The major difference between the current investigation and these earlier studies was the 
inclusion of the wrist cuff,  as is traditionally done with strain gauge plethysmography,[21] to 
exclude the hand circulation, thus forming a completely sealed forearm compartment. The wrist 
cuff may minimize red cell redistribution across AV anastomoses between the distal ends of the 
radial and ulnar arteries and veins in the distal wrist and proximal hand[95]. Figure 3 shows a 
single trial where the wrist cuff is inflated following a 60 second baseline reading. As the cuff is 
pressurized there was a temporary reduction of T[Hb+Mb], but it returned to baseline within 30-
45 seconds. These results suggest that the addition of a wrist cuff inflated to suprasystolic 
pressure may eliminate the accumulation of T[Hb+Mb] without impacting baseline T[Hb+Mb] 
values in the long term.   
 CONCLUSION 
 In conclusion, our results show that the inhibition of prostaglandin formation with the 
non-selective COX inhibitor ibuprofen slows the initial T[Hb+Mb] response (τ1 and time to 
peak) to a 5-minute ischemic cuff occlusion of the brachial artery. Our results also suggest that 
time series analysis of the microvascular hematocrit response may be a more sensitive technique 
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for detecting changes in microvascular reactivity that is the traditional measures of forearm 
blood flow collected with SGP. These results support claims that vasodilator prostaglandins play 
a role in the initial changes in T[Hb+Mb] during PORH within skeletal muscle, but not within 
cutaneous tissue. Our findings also suggest that the addition of a wrist cuff may minimize 
T[Hb+Mb] accumulation during ischemic cuff occlusion. Finally, our results suggest that caution 
is warranted when interpreting changes in NIRS responses including, microvascular hematocrit  
among clinical populations and among individuals using NSAIDs.    
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Table 0-1: Time constants in seconds listed as mean(SD). 
Time Constant τ1 τ 2 
Treatment IBU PLA IBU PLA 
T[Hb+Mb] 4.3(2.2)*† 2.8(1.1)* 67.7(32.5)‡ 55.2(20.2)‡ 
CVC, Proximal 3.3(1)* 2.7(1.3)* 46.2(19.2)‡ 51.9(47.9)‡ 
CVC, Distal 8.0(11.9)* 11.5(13.4)* 71.2(54.2)‡ 44(20.7)‡ 
BABF 8.1(7.3)* 7.4(3.9)* 19.1(8.8) 19.9(12.1) 
T[Hb+Mb], Total hemoglobin+myoglobin 
CVC, Cutaneous vascular conductance 
BABF, Brachial artery blood flow 
* =significantly faster than τ2  
† = significantly longer than placebo (p=0.014) 
‡ = Significantly longer than BABF (p<0.001) 
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Table 0-2: Time to peak (s) and total hyperemic response (AUC) for each response listed as 
mean(SD). 
 Treatment IBU PLA 
T
im
e 
to
 P
ea
k
 
T[Hb+Mb] 14.5 (5.4)† 8.8 (2.9) 
CVC, 
Proximal 11.4 (3.4) 10.1 (3.9) 
CVC, Distal 16.6 (6) 15.1 (10.6) 
BABF 14.3 (5.9 10.4 (6.3) 
A
U
C
 
T[Hb+Mb] 931 (342) 1015 (262) 
CVC, 
Proximal 48.8 (16.9) 39.3 (15.2) 
CVC, Distal 38.0 (11.6) 30.8 (11.6) 
BABF 559 (246) 513 (275) 
 
 
† = significantly longer than placebo (p=0.002) 
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Table 0-3: Baseline and amplitude parameters for all responses listed as mean (SD).  
 
 Y0 A1 A2 
Treatment IBU PLA IBU PLA IBU PLA 
T[Hb+Mb]* 123.5(7.4) 116.4(17.6) 40.1(1.5) 38.3(3.3) 43.9(7.8) 41.2(4.9) 
CVC, 
Proximal 
0.2(0.2) 0.1(0.1) 1.3(0.5) 1.2(0.3) 1.2(0.5) 1.0(0.3) 
CVC, Distal 0.1(0.1) 0.2(0.2) 1.2(0.7) 1.1(0.6) 1.0(0.8) 1.0(0.6) 
BABF 1.7(0.6) 1.7(0.8) 28.7(27.5) 35.0(34.1) 31.7(28.4) 35.1(33.4) 
 
*-Corrected for ATT 
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Figure 0-1: Protocol schematic showing 60 second baseline period, 5-minutes of cuff occlusion, 
cuff release and PORH in cutaneous tissue, proximal skin probe, for both placebo and ibuprofen 
treatments. 
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Figure 0-2: T[Hb+Mb] during PORH with baseline(Y0) and amplitude indicators for both 
placebo and ibuprofen treatments. Same subject from Figure 1. 
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Figure 0-3: Wrist cuff inflation at 60 seconds resulted in a temporary alteration in T[Hb+Mb]. 
Values returned to baseline within 60-120 seconds.  
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Chapter 6 - Conclusion 
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In conclusion, during a period of ischemic cuff occlusion of the brachial artery, 
deoxy[Hb+Mb] increases and oxy[Hb+Mb] decreases as oxygen is removed from hemoglobin 
and myoglobin in the forearm vascular compartment.[9] Upon cuff release reactive hyperemia 
occurs in the brachial artery resulting in a temporary abatement of the Fahraeus effect and an 
increase in microvascular hematocrit, seen with NIRS as a transient increase in T[Hb+Mb]. As 
ischemia ends and oxygen rich blood once again flows through the brachial artery, oxy[Hb+Mb] 
increases and deoxy[Hb+Mb] decreases; the increased T[Hb+Mb] response is only seen because 
the oxy[Hb+Mb] response is faster than the deoxy[Hb+Mb] response. Recovery kinetics (τ2) 
were correlated between T[Hb+Mb] and brachial artery blood flow, however, the brachial artery 
response is significantly faster than either cutaneous or skeletal muscle microvascular responses 
in τ1 and time to peak. In comparisons between cutaneous and skeletal muscle microvascular 
responses no differences in temporal profiles were observed indicating that the cutaneous 
microvasculature can serve as a surrogate for the skeletal muscle microvasculature during a 
temporal analysis of PORH responses in the human forearm. Finally, inhibition of prostaglandin 
formation with oral ibuprofen slows the initial T[Hb+Mb] response, following a 5-minute 
ischemic episode indicating that prostaglandins are responsible, at least partially, for the initial 
T[Hb+Mb] response in skeletal muscle, but not within the cutaneous microvasculature. The 
addition of a wrist cuff to a PORH protocol can prevent the accumulation of T[Hb+Mb] during 
the ischemic cuff occlusion that has plagued this technique since it was first used.  
 While this dissertation has described and attempted to explain mechanisms behind the 
T[Hb+Mb] response during PORH, there are some questions that remain to be answered. 
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Chiefly, what exactly is the T[Hb+Mb] response measuring? We have made the case that 
changes in T[Hb+Mb] reflect changes in microvascular hematocrit, but to my knowledge, no 
direct comparisons between the two have been made. We also observed differences in temporal 
profiles within the same skeletal muscle microvasculture as measured with NIRS and 
intramuscular laser-Doppler devices. The technical and physiological differences behind these 
distinct profiles are unknown at this time. Lastly, in light of recent evidence suggesting that 
microvascular reactive hyperemia is more predictive of cardiovascular disease than measures 
derived from the conduit artery[1, 4, 5], does the ability to assess microvascular reactive 
hyperemia within skeletal muscle offer clinical utility beyond traditional measures. Of 
microvascular reactive hyperemia in the cutaneous tissue? The answers to these questions must 
await future work.         
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